Maxim Integrated Products (MXIM) 10-Q 1 Feb 19 2019 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information Document - shares	3 Months Ended	6 Months Ended
	Dec. 29, 2018	Dec. 29, 2018	Jan. 24, 2019
DEI [Abstract]
Entity Registrant Name		MAXIM INTEGRATED PRODUCTS INC
Entity Central Index Key		743,316
Trading Symbol	MXIM
Document Type		10-Q
Amendment Flag		false
Document Period End Date		Dec. 29, 2018
Document Fiscal Year Focus		2,019
Document Fiscal Period Focus		Q2
Entity Emerging Growth Company	false
Entity Small Business	false
Current Fiscal Year End Date		--06-29
Entity Filer Category		Large Accelerated Filer
Entity Common Stock, Shares Outstanding			273,398,340

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 29, 2018	Jun. 30, 2018
Finite-Lived Intangible Assets, Gross	$ 617,825	$ 613,599
Current assets:
Cash and cash equivalents	1,406,740	1,543,484
Short-term Investments	553,901	1,082,915
Total cash, cash equivalents and short-term investments	1,960,641	2,626,399
Accounts receivable, net	391,419	280,072
Inventories	278,925	282,390
Other assets current	26,933	21,548
Total current assets	2,657,918	3,210,409
Property, plant and equipment, net	571,983	579,364
Intangible assets, net	67,161	78,246
Goodwill	532,251	532,251
Other assets noncurrent	59,614	51,291
TOTAL ASSETS	3,888,927	4,451,561
Current liabilities:
Accounts payable	99,577	92,572
Price adjustment and other revenue reserves	130,601	0
Income taxes payable	39,507	17,961
Accrued salary and related expenses	102,427	151,682
Accrued expenses	34,368	35,774
Short-term Debt	0	499,406
Total current liabilities	406,480	797,395
Long term debt	991,866	991,147
Income taxes payable	673,051	661,336
Other liabilities	62,116	70,743
Total liabilities	2,133,513	2,520,621
Commitments and contingencies (Note 11)
Stockholders' equity:
Common stock and capital in excess of par value	279	279
Retained earnings	1,766,471	1,945,646
Accumulated other comprehensive loss	(11,336)	(14,985)
Total stockholders' equity	1,755,414	1,930,940
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY	3,888,927	4,451,561
Intellectual Property [Member]
Finite-Lived Intangible Assets, Gross	$ 488,846	$ 485,465

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets Parenthetical - USD ($) $ in Thousands	Dec. 29, 2018	Jun. 30, 2018
Statement of Financial Position [Abstract]
Allowance for Doubtful Accounts Receivable, Current	$ 136	$ 140,296

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 29, 2018	Dec. 30, 2017
Interest Expense	$ 11,700	$ 12,500	$ 24,600	$ 25,100
Interest Expense, Debt	11,200	12,400	23,600	24,700
Allocated Share-based Compensation Expense	21,656	21,038	42,153	38,327
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	2,304	1,887	4,268	4,777
Allocated Share-based Compensation Expense, Net of Tax	19,352	19,151	37,885	33,550
Revenue from Contract with Customer, Excluding Assessed Tax	576,906	622,637	1,215,401	1,198,313
Cost of Revenue	203,858	212,961	412,117	414,806
Net revenues	576,906	622,637	1,215,401	1,198,313
Gross margin	373,048	409,676	803,284	783,507
Operating expenses:
Research and development	110,303	115,896	223,011	224,497
Selling, general and administrative	77,853	85,323	159,372	159,005
Amortization of Intangible Assets	756	995	1,529	2,747
Asset Impairment Charges	753	850	753	892
Severance and Restructuring Charges	1,179	6,523	2,173	11,956
Other Operating Income (Expense), Net	0	(959)	60	(1,804)
Total operating expenses	190,844	208,628	386,898	397,293
Operating income	182,204	201,048	416,386	386,214
Interest and other expense, net	472	(3,121)	(74)	(7,334)
Income before provision for income taxes	182,676	197,927	416,312	378,880
Provision for income taxes	50,784	272,942	86,997	299,361
Net income	$ 131,892	$ (75,015)	$ 329,315	$ 79,519
Earnings per share:
Basic (per share)	$ 0.48	$ (0.27)	$ 1.19	$ 0.28
Diluted (per share)	$ 0.47	$ (0.27)	$ 1.17	$ 0.28
Shares used in the calculation of earnings per share:
Basic (in shares)	276,252	281,560	277,144	281,852
Diluted (in shares)	280,008	281,560	281,414	286,355
Employee Stock Option [Member]
Allocated Share-based Compensation Expense	$ 78	$ 482	$ 155	$ 1,239
Restricted Stock Units (RSUs) [Member]
Allocated Share-based Compensation Expense	19,350	18,498
ESP Plan [Member]
Allocated Share-based Compensation Expense	2,228	2,058	4,551	4,035
Restricted Stock [Member]
Allocated Share-based Compensation Expense			37,447	33,053
Cost of Sales [Member]
Allocated Share-based Compensation Expense	2,388	2,486	4,667	4,887
Cost of Sales [Member] | Employee Stock Option [Member]
Allocated Share-based Compensation Expense	9	75	19	161
Cost of Sales [Member] | Restricted Stock Units (RSUs) [Member]
Allocated Share-based Compensation Expense	1,884	1,944	3,646	3,780
Cost of Sales [Member] | ESP Plan [Member]
Allocated Share-based Compensation Expense	495	467	1,002	946
Research and Development Expense [Member]
Allocated Share-based Compensation Expense	9,839	10,116	19,696	17,983
Research and Development Expense [Member] | Employee Stock Option [Member]
Allocated Share-based Compensation Expense	11	185	22	493
Research and Development Expense [Member] | Restricted Stock Units (RSUs) [Member]
Allocated Share-based Compensation Expense	8,693	8,898	17,384	15,487
Research and Development Expense [Member] | ESP Plan [Member]
Allocated Share-based Compensation Expense	$ 1,135	$ 1,033	2,290	2,003
Selling, General and Administrative Expenses [Member]
Allocated Share-based Compensation Expense			17,790	15,457
Selling, General and Administrative Expenses [Member] | Employee Stock Option [Member]
Allocated Share-based Compensation Expense			114	585
Selling, General and Administrative Expenses [Member] | Restricted Stock Units (RSUs) [Member]
Allocated Share-based Compensation Expense			16,417	13,786
Selling, General and Administrative Expenses [Member] | ESP Plan [Member]
Allocated Share-based Compensation Expense			$ 1,259	$ 1,086

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 29, 2018	Dec. 30, 2017
Statements of Income and Comprehensive Income [Abstract]
Net income	$ 131,892	$ (75,015)	$ 329,315	$ 79,519
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax	885	(2,122)	1,977	(2,220)
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax	423	(3)	1,518	350
Unrealized gains (losses) on post-retirement benefits, net of tax benefit (expense)	76	(76)	154	(32)
Other Comprehensive Income (Loss), Net of Tax	1,384	(2,201)	3,649	(1,902)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	133,276	(77,216)	332,964	77,617
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	(201)	0	(228)	0
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax	(96)	69	(310)	(51)
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax	$ (18)	$ (142)	$ (37)	$ (164)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Payments of Stock Issuance Costs	$ (13,444)	$ (11,520)
Cash flows from operating activities:
Net income	329,315	79,519
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	42,153	38,327
Depreciation and amortization	57,994	72,567
Deferred taxes	(8,206)	8,927
Gain (Loss) on Disposition of Property Plant Equipment	(2,896)	588
Other Noncash Income (Expense)	(636)	(850)
Impaired Assets to be Disposed of by Method Other than Sale, Amount of Impairment Loss	0	42
Changes in assets and liabilities:
Accounts receivable	(19,798)	(20,759)
Inventories	(3,497)	12,290
Other current assets and income tax refund receivable	6,587	(32,947)
Accounts payable	2,401	3,664
Income taxes payable	33,261	250,597
Deferred income on shipments to distributors	0	(14,974)
Increase (Decrease) in Employee Related Liabilities	(45,783)	(31,582)
Increase (Decrease) in Other Accrued Liabilities	60	815
Net Cash Provided by (Used in) Operating Activities	431,435	449,580
Cash flows from investing activities:
Purchase of property, plant and equipment	(30,913)	(36,734)
Proceeds from sale of property, plant, and equipment	2	2,917
Proceeds from sale of available-for-sale securities	27,253	39,996
Proceeds from maturity of available-for-sale securities	718,554	118,211
Payments to Acquire Businesses, Net of Cash Acquired	(2,949)	0
Payments to Acquire Available-for-sale Securities	(214,587)	(853,470)
Payments to Acquire Investments	(906)	(2,106)
Net cash used in investing activities	496,454	(731,186)
Cash flows from financing activities:
Repayments of Long-term Debt	500,000	0
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options	17,689	14,975
Repurchase of common stock	(320,056)	(152,244)
Payments of Dividends	(254,665)	(202,883)
Payment for Contingent Consideration Liability, Financing Activities	(8,000)	0
Net Cash Provided by (Used in) Financing Activities	(1,064,633)	(333,005)
Proceeds from stock options exercised	13,843	18,667
Net decrease in cash and cash equivalents	(136,744)	(614,611)
Cash and cash equivalents:
Beginning of period	1,543,484	2,246,121
End of period	1,406,740	1,631,510
Supplemental disclosures of cash flow information:
Cash paid (refunded), net during the period for income taxes	60,946	14,857
Cash paid for interest	23,313	23,313
Noncash investing and financing activities:
Accounts payable related to property, plant, and equipment purchases	$ 14,660	$ 10,961

Condensed Consolidated Statem_4

Condensed Consolidated Statement of Shareholders' Equity Statement - USD ($) shares in Thousands, $ in Thousands		Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]
Common Stock, Shares, Outstanding		282,912
Stockholders' Equity, Other		$ 2,197,745	$ 283		$ 2,207,053	$ (9,591)
Stockholders' Equity, Other		1,985,698	$ 283		1,997,207	(11,792)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		79,519			79,519
Other Comprehensive Income (Loss), Net of Tax		(1,902)				(1,902)
Shares of common stock repurchased			(3,146)
Value of common stock repurchased		(152,246)	$ 1	$ 60,515	91,730	0
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures			519
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures		(11,520)	$ 0	(11,520)	0	0
Stock Issued During Period, Shares, Other			737
Stock Issued During Period, Value, Stock Options Exercised		18,669	$ 1	18,668	0	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition		38,392	$ 0	38,392	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans			416
Stock Issued During Period, Value, Employee Stock Ownership Plan			$ 0
Stock Issued During Period, Value, Employee Stock Purchase Plan		14,975		14,975	0	0
Dividends, Common Stock, Cash		(202,883)	$ 0	0	(202,883)	0
Stockholders' Equity, Other		1,930,940			1,945,646	(14,985)
Common Stock, Shares, Outstanding			281,731
Stockholders' Equity, Other			$ 283			(11,792)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		(75,015)			(75,015)
Other Comprehensive Income (Loss), Net of Tax		(2,201)				(2,201)
Shares of common stock repurchased			(1,488)
Value of common stock repurchased		(76,954)	$ 1	43,543	33,410	0
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures			258
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures		(6,104)	$ 0	(6,104)	0	0
Stock Issued During Period, Shares, Other			521
Stock Issued During Period, Value, Stock Options Exercised		13,508	$ 1	13,507	0	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition		21,165	$ 0	21,165	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans			416
Stock Issued During Period, Value, Employee Stock Ownership Plan			$ 0
Stock Issued During Period, Value, Employee Stock Purchase Plan		14,975		14,975	0	0
Dividends, Common Stock, Cash		$ (101,421)	0	0	(101,421)	0
Common Stock, Shares, Outstanding		281,438
Common Stock, Shares, Outstanding		278,664
Stockholders' Equity, Other		$ 1,912,323	279		1,924,764	(12,720)
Stockholders' Equity, Other		1,755,414	$ 279		1,766,471	(11,336)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		329,315			329,315
Other Comprehensive Income (Loss), Net of Tax		3,649
Shares of common stock repurchased			(5,822)
Value of common stock repurchased		(320,056)	$ 0	63,744	256,312	0
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures			578
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures		(13,444)	$ 0	(13,444)	0	0
Stock Issued During Period, Shares, Other			522
Stock Issued During Period, Value, Stock Options Exercised		13,843	$ 0	13,843	0	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition		42,185	$ 0	42,185	0	0
Modification Of Liability Instruments To Equity	[1]			3,471
Stock Issued During Period, Shares, Employee Stock Purchase Plans			0
Stock Issued During Period, Value, Employee Stock Ownership Plan			$ 0
Stock Issued During Period, Value, Employee Stock Purchase Plan		17,689		17,689	0	0
Dividends, Common Stock, Cash		(254,665)	$ 0	0	(254,665)	0
Common Stock, Shares, Outstanding			277,430
Stockholders' Equity, Other		1,755,414	$ 279		1,766,471	(11,336)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		131,892
Other Comprehensive Income (Loss), Net of Tax		1,384
Shares of common stock repurchased			(3,960)
Value of common stock repurchased		(207,558)	$ 0	44,181	163,377	0
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures			281
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures		(5,916)	$ 0	(5,916)	0	0
Stock Issued During Period, Shares, Other			191
Stock Issued During Period, Value, Stock Options Exercised		7,235	$ 0	7,235	0	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition		21,702	$ 0	21,702	0	0
Modification Of Liability Instruments To Equity	[1]			3,471
Stock Issued During Period, Shares, Employee Stock Purchase Plans			0
Stock Issued During Period, Value, Employee Stock Ownership Plan			$ 0
Stock Issued During Period, Value, Employee Stock Purchase Plan		17,689		17,689	0	0
Dividends, Common Stock, Cash		$ (126,808)	$ 0	$ 0	(126,808)	$ 0
Common Stock, Shares, Outstanding		273,942
Cumulative Effect of New Accounting Principle in Period of Adoption		$ 2,487			$ 2,487
[1]	(1) In December 2018, $3.5 million was reclassified from accrued salaries to additional paid-in capital due to a settlement agreement relating to the expiration of stock options.

Basis of Presentation

Basis of Presentation	6 Months Ended
	Dec. 29, 2018
Basis of Presentation [Abstract]
Basis of Presentation [Text Block]	BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements of Maxim Integrated Products, Inc. and all of its majority-owned subsidiaries (collectively, the “Company” or “Maxim Integrated”) included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with generally accepted accounting principles of the United States of America (“GAAP”) have been condensed or omitted pursuant to applicable rules and regulations. In the opinion of management, all adjustments of a normal recurring nature which were considered necessary for fair statement have been included. The year-end condensed consolidated balance sheet data were derived from audited consolidated financial statements but do not include all disclosures required by GAAP. The results of operations for the six months ended December 29, 2018 are not necessarily indicative of the results to be expected for the entire year. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2018 . The Company has a 52-to-53-week fiscal year that ends on the last Saturday in June. Accordingly, every fifth or sixth fiscal year will be a 53-week fiscal year. Fiscal year 2018 was a 53-week fiscal year and fiscal year 2019 is a 52-week fiscal year. The second quarter of fiscal year 2019 was a 13-week quarter and the second quarter of fiscal year 2018 was a 14-week quarter.

Recently Issued Accounting Pron

Recently Issued Accounting Pronouncements	6 Months Ended
	Dec. 29, 2018
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recently Issued Accounting Pronouncements [Text Block]	Recently Issued Accounting Pronouncements (i) New Accounting Updates Recently Adopted In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09, Revenue from Contracts with Customers (Topic 606) . This standard provides a single set of guidelines for revenue recognition to be used across all industries. Under the new standard, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires reporting companies to disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. On July 1, 2018, the Company adopted Topic 606 and related amendments (ASU 2015-14, Deferral of the Effective Date ; ASU 2016-08, Principal versus Agent Considerations ; ASU 2016-10, Identifying Performance Obligations and Licensing , ASU 2016-12, Narrow-Scope Improvements and Practical Expedients and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers ) using the modified retrospective method applied to all contracts that are not completed at the date of initial application (i.e., July 1, 2018). Results for reporting periods beginning after July 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with historic accounting standards under Topic 605. There was no impact on the opening retained earnings as of July 1, 2018 due to the adoption of Topic 606. However, in conjunction with the adoption of the new standard, the Company recorded a reclassification of accrued revenue reserves for price adjustments and other revenue reserves from accounts receivable, net to price adjustment and other revenue reserves within current liabilities. The cumulative effect of the changes to the condensed consolidated balance sheet from the adoption of Topic 606 was as follows (in thousands): As of June 30, 2018 Effect of Adoption of Topic 606 As of July 1, 2018 Accounts receivable, net $ 280,072 $ 141,652 $ 421,724 Price adjustment and other revenue reserves — 141,652 141,652 Balance Sheet Reclassification Under Topic 605, the gross amount of accrued revenue reserves for price adjustments and other revenue reserves of $141.7 million was included within accounts receivable, net as of June 30, 2018. Subsequent to the adoption of Topic 606, such balances are presented on a gross basis as accrued price adjustments and other revenue reserves of $141.7 million , which is presented in the price adjustment and other revenue reserves balance sheet caption. The adoption of Topic 606 has no impact on the total cash flows from operating, investing, or financing activities on the Condensed Consolidated Statement of Cash Flows. The following table summarizes the impacts of adopting Topic 606 on the Company’s Condensed Consolidated Balance Sheet as of December 29, 2018 (in thousands): As Reported If Reported Under Topic 605 Effect of Adoption of Topic 606 Accounts receivable, net $ 391,419 $ 260,818 $ 130,601 Price adjustment and other revenue reserves 130,601 — 130,601 Practical Expedients and Elections • The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which the Company recognizes revenue at the amount to which it has the right to invoice for services performed. • The Company has elected to account for shipping and handling costs as fulfillment costs after the customer obtains control of the goods. • The Company has elected to exclude sales, use, value added, and some excise taxes, if applicable, from the measurement of the transaction price. The transaction price excludes sales and other similar taxes. Updated Revenue Recognition Policy The Company recognizes revenue for sales to direct customers and distribution customers ("distributors") when a customer obtains control of promised goods or services in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. The transaction price is calculated as selling price net of variable considerations, such as distributor price adjustments. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it is expected to be entitled. The transaction price does not include amounts collected on behalf of another party, such as sales taxes or value added tax. The Company elected the practical expedient to not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company estimates returns for sales to direct customers and distributors based on historical return rates applied against current period gross revenue. Specific customer returns and allowances are considered within this estimate. Accounts receivable from direct customers and distributors are recognized and inventory is relieved upon shipment as title to inventories generally transfers upon shipment, at which point the Company has a legally enforceable right to collection under normal terms. Accounts receivable related to consigned inventory is recognized when the customer takes title to such inventory from its consigned location, at which point inventory is relieved, title transfers, and the Company has a legally enforceable right to collection under the terms of the agreement with the related customers. Customers are generally required to pay for products and services within the Company’s standard terms, which is net 30 days from the date of invoice. The Company does not have any significant financing components greater than one year. The Company estimates potential future returns and sales allowances related to current period product revenue. Management analyzes historical returns, changes in customer demand and acceptance of products when evaluating the adequacy of returns and sales allowances. Estimates made may differ from actual returns and sales allowances. These differences may materially impact reported revenue and amounts ultimately collected on accounts receivable. Historically, such differences have not been material. Distributor price adjustments are estimated based on the Company's historical experience rates and also considering economic conditions and contractual terms. To date, actual distributor claims activity has been materially consistent with the estimates that the Company has made based on its historical rates. The Company's revenue arrangements do not contain significant financing components. Revenue is recognized over a period of time when it is assessed that performance obligations are satisfied over a period rather than at a point in time. When any of the following criteria is fulfilled, revenue is recognized over a period of time: (a) The customer simultaneously receives and consumes the benefits provided by the performance completed. (b) Performance creates or enhances an asset (for example, work in process) that the customer controls as the asset is created or enhanced. (c) Performance does not create an asset with an alternative use, and has an enforceable right to payment for performance completed to date. In January 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, with further classifications made recently with the issuance of ASU 2018-03 and ASU 2018-04, which provides guidance for the recognition, measurement, presentation, and disclosure of financial assets and liabilities. The application of this ASU was made by the means of a cumulative-effect adjustment to the balance sheet for the equity securities that qualify for the practical expedient to estimate fair value using the net asset value per share. The amendments related to equity securities without readily determinable fair values (including disclosure requirements) is being applied prospectively to equity investments that exist as of the date of adoption. The Company adopted ASU 2016-01 in the first quarter of fiscal year 2019. As a result of this adoption, the Company recognized an increase of $2.5 million , net of tax, in retained earnings at the beginning of fiscal year 2019. In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory . ASU 2016-16 requires that entities recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs instead of when the asset is sold. The Company adopted ASU 2016-16 in the first quarter of fiscal year 2019. The adoption of this guidance did not have an impact on the Company's consolidated financial statements. In March 2017, the FASB issued ASU 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost , which requires employers that offer or maintain defined benefit plans to disaggregate the service component from the other components of net benefit cost and provides guidance on presentation of the service component and the other components of net benefit cost in the statement of operations. The application of ASU 2017-07 requires retrospective basis for all periods presented. The Company adopted ASU 2017-07 in the first quarter of fiscal year 2019. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements. In May 2017, the FASB issued ASU 2017-09, Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting. The amendments in this standard provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. Unless the changes in terms or conditions meet all three criteria outlined in the guidance, modification accounting should be applied. The three criteria relate to changes in the terms and conditions that affect the fair value, vesting conditions, or classification of a share-based payment award. The guidance is required to be applied prospectively to an award modified on or after the adoption date. The Company adopted ASU 2017-09 in the first quarter of fiscal year 2019. The adoption of this guidance did not have an impact on the Company's consolidated financial statements. In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income . This standard provides guidance about the reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act. The Company adopted ASU 2018-02 in the first quarter of fiscal year 2019. There was no material change to the Company's consolidated financial statements as a result of this adoption. In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Non-employee Share-Based Payment Accounting . This ASU largely aligns the accounting for share-based payment awards to employees and non-employees. Under the new guidance, both sets of awards, for employees and non-employees, will essentially follow the same model, with small discrepancies related to the term assumption when valuing non-employee awards. The Company adopted ASU 2018-07 in the first quarter of fiscal year 2019. The adoption of this guidance did not have an impact on the Company's consolidated financial statements. SEC Disclosure Update and Simplification. In August 2018, the SEC adopted a final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, which amends certain disclosure requirements that were redundant and outdated. The rule also requires registrants to include in their interim financial statements a reconciliation of changes in stockholders' equity in the notes or as a separate statement. The final rule was effective on November 5, 2018. The Company has adopted the final rule as of December 29, 2018, and has included a reconciliation of the changes in stockholders' equity in this Form 10-Q. (ii) Recent Accounting Updates Not Yet Effective In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) , which supersedes the lease accounting requirements in Topic 840. ASU 2016-02 requires a dual approach for lessee accounting under which a lessee would account for leases as finance leases or operating leases. Both finance leases and operating leases will result in the lessee recognizing a right-of-use asset and a corresponding lease liability. For finance leases, the lessee would recognize interest expense and amortization of the right-of-use asset, and for operating leases, the lessee would recognize a straight-line total lease expense. The guidance also requires qualitative and specific quantitative disclosures to supplement the amounts recorded in the financial statements so that users can understand more about the nature of an entity’s leasing activities, including significant judgments and changes in judgments. This guidance is effective beginning in the first quarter of fiscal year 2020 on a modified retrospective approach. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements and expects that there will be an increase in assets and liabilities on the Consolidated Balance Sheets at adoption due to the recognition of right-of-use assets and related lease liabilities. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which improves disclosures by removing, modifying and adding disclosure requirements related to fair value measurements. The update highlights adjustments in disclosures for changes in the fair value of Level 1, Level 2, and Level 3 instruments. This guidance is effective beginning in the first quarter of fiscal year 2021, with early adoption permitted. The Company does not believe that this update will have a material impact on its consolidated financial statements.

Balance Sheet Components

Balance Sheet Components	6 Months Ended
	Dec. 29, 2018
Balance Sheet Related Disclosures [Abstract]
Balance Sheet Components [Text Block]	BALANCE SHEET COMPONENTS Inventories consist of: December 29, June 30, Inventories: (in thousands) Raw materials $ 16,832 $ 16,251 Work-in-process 171,287 173,859 Finished goods 90,806 92,280 $ 278,925 $ 282,390 Property, plant and equipment, net consists of: December 29, June 30, Property, plant and equipment, net: (in thousands) Land $ 17,731 $ 17,731 Buildings and building improvements 258,679 254,733 Machinery, equipment and software 1,339,552 1,309,487 1,615,962 1,581,951 Less: accumulated depreciation (1,043,979 ) (1,002,587 ) $ 571,983 $ 579,364 Accrued salary and related expenses consist of: December 29, June 30, Accrued salary and related expenses: (in thousands) Accrued vacation $ 31,914 $ 30,695 Accrued bonus 43,511 92,288 Accrued salaries 8,616 8,210 ESPP withholding 4,267 5,158 Accrued fringe benefits 8,279 4,752 Other 5,840 10,579 $ 102,427 $ 151,682

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Dec. 29, 2018
Fair Value Disclosures [Abstract]
Fair Value Measurements [Text Block]	FAIR VALUE MEASUREMENTS The FASB established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Three levels of inputs that may be used to measure fair value are as follows: Level 1 - Quoted (unadjusted) prices in active markets for identical assets or liabilities. The Company’s Level 1 assets consist of money market funds. Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. The Company’s Level 2 assets and liabilities consist of U.S. Treasury securities, agency securities, corporate debt securities, certificates of deposit, commercial paper and foreign currency forward contracts that are valued using quoted market prices or are determined using a yield curve model based on current market rates. Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company's Level 3 assets and liabilities consist of acquisition related contingent consideration liabilities. Assets and liabilities measured at fair value on a recurring basis were as follows: As of December 29, 2018 As of June 30, 2018 Fair Value Measurements Using Total Fair Value Measurements Using Total Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 (in thousands) Assets Cash and cash equivalents Agency securities $ — $ — $ — $ — $ — $ 13,946 $ — $ 13,946 Certificates of deposit — 1,000 — 1,000 — 6,000 — 6,000 Commercial paper — — — — — 45,063 — 45,063 Corporate debt securities — — — — — 3,819 — 3,819 Money market funds 167,698 — — 167,698 98,467 — — 98,467 U.S. Treasury securities — — — — — 30,988 — 30,988 Short term investments Certificates of deposit — 34,997 — 34,997 — 52,428 — 52,428 Commercial paper — 38,437 — 38,437 — 64,354 — 64,354 Corporate debt securities — 263,562 — 263,562 — 367,765 — 367,765 U.S. Treasury securities — 216,905 — 216,905 — 598,368 — 598,368 Other current assets Foreign currency forward contracts — 418 — 418 — 235 — 235 Total assets $ 167,698 $ 555,319 $ — $ 723,017 $ 98,467 $ 1,182,966 $ — $ 1,281,433 Liabilities Accrued expenses Foreign currency forward contracts $ — $ 270 $ — $ 270 $ — $ 1,845 $ — $ 1,845 Contingent consideration — — 9,052 9,052 — — 8,000 8,000 Other liabilities Contingent consideration — — 1,052 1,052 — — 8,000 8,000 Total Liabilities $ — $ 270 $ 10,104 $ 10,374 $ — $ 1,845 $ 16,000 $ 17,845 During the six months ended December 29, 2018 and the year ended June 30, 2018 , there were no transfers in or out of Level 3 from other levels in the fair value hierarchy. There were no assets or liabilities measured at fair value on a non-recurring basis as of December 29, 2018 and June 30, 2018 other than impairments of long-lived assets. The Company uses various inputs to evaluate investments in privately held companies, including valuations of recent financing events as well as other relevant information regarding the performance of the issuer. During the three and six months ended December 29, 2018 , the Company recorded $0.8 million , in impairment of long-lived assets in the Company's Condensed Consolidated Statements of Income. For the fiscal year ended June 30, 2018 , the Company recorded $0.9 million in impairment of long-lived assets in the Company's Consolidated Statements of Income.

Financial Instruments

Financial Instruments	6 Months Ended
	Dec. 29, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments [Text Block]	FINANCIAL INSTRUMENTS Short-term investments Fair values were as follows: December 29, June 30, Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value (in thousands) Available-for-sale investments Certificates of deposit $ 34,997 $ — $ — $ 34,997 $ 52,429 $ — $ (1 ) $ 52,428 Commercial paper 38,437 — — 38,437 64,354 — — 64,354 Corporate debt securities 264,880 — (1,318 ) 263,562 369,734 39 (2,008 ) 367,765 U.S. Treasury securities 217,280 1 (376 ) 216,905 600,068 10 (1,710 ) 598,368 Total available-for-sale investments $ 555,594 $ 1 $ (1,694 ) $ 553,901 $ 1,086,585 $ 49 $ (3,719 ) $ 1,082,915 In the three and six months ended December 29, 2018 and June 30, 2018 , the Company did not recognize any impairment charges on short-term investments. All available-for-sale investments have maturity dates between December 29, 2018 and March 12, 2021. The Company invests in various financial instruments including U.S. Treasury securities, corporate debt securities, commercial paper, and certificates of deposit which include instruments issued or managed by industrial, financial, and utility institutions and U.S. Treasury securities which include U.S. government Treasury bills and Treasury notes. Derivative instruments and hedging activities The Company incurs expenditures denominated in non-U.S. currencies, primarily the Philippine Peso and the Thai Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and the European Euro, Indian Rupee, Japanese Yen, Taiwan New Dollar, South Korean Won, Chinese Yuan and Canadian Dollar, for sales offices and research and development activities undertaken outside of the U.S. The Company has established a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures. The Company does not use these foreign currency forward contracts for trading purposes. Derivatives designated as cash flow hedging instruments The Company designates certain forward contracts as hedging instruments pursuant to Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging (“ASC 815”). As of December 29, 2018 and June 30, 2018 , the notional amounts of the forward contracts the Company held to purchase international currencies were $42.2 million and $49.7 million , respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $0.3 million and $1.2 million , respectively. Derivatives not designated as hedging instruments As of December 29, 2018 and June 30, 2018 , the notional amounts of the forward contracts the Company held to purchase international currencies were $19.8 million and $21.1 million , respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $19.0 million and $21.3 million , respectively. The fair values of the Company's outstanding foreign currency forward contracts and gain (loss) included in the Condensed Consolidated Statements of Income were not material for the three and six months ended December 29, 2018 and December 30, 2017 . Effect of hedge accounting on the Condensed Consolidated Statements of Income The following table summarizes the gains (losses) from hedging activities recognized in the Company's Condensed Consolidated Statements of Income: Three Months Ended Six Months Ended December 29, 2018 December 29, 2018 Net Revenue Cost of Goods Sold Operating Expenses Net Revenue Cost of Goods Sold Operating Expenses (in thousands) Income and expenses line items in which the effects of cash flow hedges are recorded $ 576,906 $ 203,858 $ 190,844 $ 1,215,401 $ 412,117 $ 386,898 Gain (loss) on cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income $ 5 $ (82 ) $ (602 ) $ 44 (596 ) (1,827 ) Outstanding debt obligations The following table summarizes the Company’s outstanding debt obligations: December 29, 2018 June 30, 2018 (in thousands) 3.45% fixed rate notes due June 2027 $ 500,000 $ 500,000 2.5% fixed rate notes due November 2018 — 500,000 3.375% fixed rate notes due March 2023 500,000 500,000 Total outstanding debt 1,000,000 1,500,000 Less: Current portion (included in "Current portion of debt") — (499,406 ) Less: Reduction for unamortized discount and debt issuance costs (8,134 ) (9,447 ) Total long-term debt $ 991,866 $ 991,147 On June 15, 2017, the Company completed a public offering of $500 million aggregate principal amount of the Company's 3.45% senior unsecured and unsubordinated notes due in June 2027 (“2027 Notes”), with an effective interest rate of 3.5% . Interest on the 2027 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, commencing on December 15, 2017. The net proceeds of this offering were approximately $495.2 million , after issuing at a discount and deducting paid expenses. On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% coupon senior unsecured and unsubordinated notes due in November 2018 (“2018 Notes”), with an effective interest rate of 2.6% . Interest on the 2018 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing on May 15, 2014. The net proceeds of this offering were approximately $494.5 million , after issuing at a discount and deducting paid expenses. In November of 2018, the Company repaid the entire $500 million in principal and any outstanding interest, related to these outstanding notes. On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 3.375% senior unsecured and unsubordinated notes due in March 2023 (“2023 Notes”), with an effective interest rate of 3.5% . Interest on the 2023 Notes is payable semi-annually in arrears on March 15 and September 15 of each year. The net proceeds of this offering were approximately $490.0 million , after issuing at a discount and deducting paid expenses. The debt indentures that govern the 2027 Notes and the 2023 Notes include covenants that limit the Company's ability to grant liens on its facilities and to enter into sale and leaseback transactions, which could limit the Company's ability to secure additional debt funding in the future. In circumstances involving a change of control of the Company followed by a downgrade of the rating of the 2027 Notes or the 2023 Notes, the Company would be required to make an offer to repurchase the affected notes at a purchase price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest. The Company accounts for all the notes above based on their amortized cost. The discount and expenses are being amortized to Interest and other income (expense), net in the Condensed Consolidated Statements of Income over the life of the notes. The interest expense is recorded in Interest and other income (expense), net in the Condensed Consolidated Statements of Income. Amortized discount and expenses, as well as interest expense associated with the notes, were $11.2 million and $12.4 million during the three months ended December 29, 2018 and December 30, 2017 , respectively. Amortized discount and expenses, as well as interest expense associated with the notes, were $23.6 million and $24.7 million , respectively, during the six months ended December 29, 2018 and December 30, 2017 . The estimated fair value of the Company’s outstanding debt obligations was approximately $955 million as of December 29, 2018 . The estimated fair value of the debt is based primarily on observable market inputs and is a Level 2 measurement. The Company recorded interest expense of $11.7 million and $12.5 million during the three months ended December 29, 2018 , and December 30, 2017 , respectively. The Company recorded interest expense of $24.6 million and $25.1 million during the six months ended December 29, 2018 and December 30, 2017 , respectively. Credit Facility Revolving credit facility As of December 29, 2018, the Company had access to a $350 million senior unsecured revolving credit facility with certain institutional lenders that expires on June 27, 2019. The facility fee is at a rate per annum that varies based on the Company’s index debt rating and any advances under the credit agreement will accrue interest at a base rate plus a margin based on the Company’s index debt rating. The credit agreement required the Company to comply with certain covenants, including a requirement that the Company maintain a ratio of debt to EBITDA (earnings before interest, taxes, depreciation, and amortization) of not more than 3 to 1 and a minimum interest coverage ratio (EBITDA divided by interest expense) greater than 3.5 to 1 . As of December 29, 2018 , the Company had not borrowed any amounts from this credit facility and was in compliance with all debt covenants. Effective January 22, 2019, the Company terminated this revolving credit facility. Other Financial Instruments For the balance of the Company’s financial instruments, cash equivalents, accounts receivable, accounts payable and other accrued liabilities, the carrying amounts approximate fair value due to their short maturities.

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Dec. 29, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation [Text Block]	STOCK-BASED COMPENSATION At December 29, 2018 , the Company had one stock incentive plan, the Company's 1996 Stock Incentive Plan (the “1996 Plan”) and one employee stock purchase plan, the 2008 Employee Stock Purchase Plan (the “2008 ESPP”). The 1996 Plan was adopted by the board of directors to provide the grant of incentive stock options, non-statutory stock options, restricted stock units (“RSUs”), and market stock units (“MSUs”) to employees, directors, and consultants. Pursuant to the 1996 Plan, the exercise price for incentive stock options and non-statutory stock options is determined to be the fair market value of the underlying shares on the date of grant. Options typically vest ratably over a four-year period measured from the date of grant. Options generally expire no later than seven years after the date of grant, subject to earlier termination upon an optionee's cessation of employment or service. RSUs granted to employees typically vest ratably over a four-year period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period. RSUs granted after August 2017 will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements. MSUs granted to employees typically vest over a four-year cliff period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period. The number of shares that are released at the end of the performance period can range from zero to a maximum cap depending on the Company's performance. MSUs granted after August 2017 will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements. The following tables show total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and six months ended December 29, 2018 and December 30, 2017 , respectively: Three Months Ended December 29, 2018 December 30, 2017 Stock Options Restricted Stock Units Employee Stock Purchase Plan Total Stock Options Restricted Stock Units Employee Stock Purchase Plan Total (in thousands) Cost of goods sold $ 9 $ 1,884 $ 495 $ 2,388 $ 75 $ 1,944 $ 467 $ 2,486 Research and development 11 8,693 1,135 9,839 185 8,898 1,033 10,116 Selling, general and administrative 58 8,773 598 9,429 222 7,656 558 8,436 Pre-tax stock-based compensation expense $ 78 $ 19,350 $ 2,228 $ 21,656 $ 482 $ 18,498 $ 2,058 $ 21,038 Less: income tax effect 2,304 1,887 Net stock-based compensation expense $ 19,352 $ 19,151 Six Months Ended December 29, 2018 December 30, 2017 Stock Options Restricted Stock Units Employee Stock Purchase Plan Total Stock Options Restricted Stock Units Employee Stock Purchase Plan Total (in thousands) Cost of goods sold $ 19 $ 3,646 $ 1,002 $ 4,667 $ 161 $ 3,780 $ 946 $ 4,887 Research and development 22 17,384 2,290 19,696 493 15,487 2,003 17,983 Selling, general and administrative 114 16,417 1,259 17,790 585 13,786 1,086 15,457 Pre-tax stock-based compensation expense $ 155 $ 37,447 $ 4,551 $ 42,153 $ 1,239 $ 33,053 $ 4,035 $ 38,327 Less: income tax effect 4,268 4,777 Net stock-based compensation expense $ 37,885 $ 33,550 The expenses included in the Condensed Consolidated Statements of Income for RSUs include expenses related to MSUs of $2.9 million and $2.2 million for the three months ended December 29, 2018 and December 30, 2017 , respectively and $5.3 million and $3.6 million for the six months ended December 29, 2018 and December 30, 2017 , respectively. Stock Options The fair value of options granted to employees under the 1996 Plan is estimated on the date of grant using the Black-Scholes option valuation model. There were no stock options granted in the three and six months ended December 29, 2018 and December 30, 2017 . The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of December 29, 2018 and related activity for the six months ended December 29, 2018 : Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (in Years) Aggregate Intrinsic Value (1) Balance at June 30, 2018 1,688,253 $ 27.72 Options Granted — Options Exercised (522,499 ) 26.96 Options Cancelled (3,439 ) 28.08 Balance at December 29, 2018 1,162,315 $ 28.06 1.5 $ 24,126,273 Exercisable, December 29, 2018 1,162,315 $ 28.06 1.5 $ 24,126,273 Vested and expected to vest, December 29, 2018 1,162,315 $ 28.06 1.5 $ 24,126,273 (1) Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on December 28, 2018, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of December 29, 2018. As of December 29, 2018 , there was no unrecognized stock compensation from unvested stock options. Restricted Stock Units and Other Awards The fair value of RSUs and other awards under the Company’s 1996 Plan is estimated using the value of the Company’s common stock on the date of grant, reduced by the present value of dividends expected to be paid on the Company’s common stock prior to vesting. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis. The weighted-average fair value of RSUs and other awards granted was $50.90 and $50.36 per share for the three months ended December 29, 2018 and December 30, 2017 , respectively, and 54.71 and $42.41 per share for the six months ended December 29, 2018 and December 30, 2017 , respectively. The following table summarizes the outstanding and expected to vest RSUs and other awards as of December 29, 2018 and related activity during the six months ended December 29, 2018 : Number of Shares Weighted Average Aggregate Intrinsic Value (1) Balance at June 30, 2018 5,524,432 Restricted stock units and other awards granted 1,321,125 Restricted stock units and other awards released (802,916 ) Restricted stock units and other awards cancelled (325,807 ) Balance at December 29, 2018 5,716,834 2.9 $ 279,095,836 Outstanding and expected to vest, December 29, 2018 4,743,351 2.8 $ 231,570,395 (1) Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on December 28, 2018, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of December 29, 2018. The Company withheld shares totaling $5.9 million and $13.4 million , respectively, in value as a result of employee withholding taxes based on the value of RSUs on vesting date for the three and six months ended December 29, 2018 . Total payments for employees’ tax obligations to taxing authorities are reflected as financing activities within the Condensed Consolidated Statements of Cash Flows. As of December 29, 2018 , there was $170.4 million of unrecognized compensation expense related to 5.7 million unvested RSUs and other awards, which is expected to be recognized over a weighted average period of approximately 2.9 years . Market Stock Units (MSUs) The Company grants MSUs to senior members of management in lieu of granting stock options. For MSUs granted prior to September 2017, the performance metrics of this program are based on relative performance of the Company’s stock price as compared to the Semiconductor Exchange Traded Fund index SPDR S&P (the “XSD”). For MSUs granted in September 2017 and after, the performance metrics for this program are based on the total shareholder return ("TSR") of the Company relative to the TSR of the other companies included in the XSD. The fair value of MSUs is estimated using a Monte Carlo simulation model on the date of grant. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis. Compensation expense is recognized based on the initial valuation and is not subsequently adjusted as a result of the Company’s performance relative to that of the XSD or the TSR of the companies included in the XSD, as applicable. Vesting for MSUs is contingent upon both service and market conditions and has a four-year vesting cliff period. MSUs granted after August 2017 vest based upon annual performance and are subject to continued service through the end of the four-year period, but will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements. The weighted-average fair value of MSUs granted was $75.48 and $51.03 per share for the six months ended December 29, 2018 and December 30, 2017 , respectively. The following table summarizes the number of MSUs outstanding and expected to vest as of December 29, 2018 and their activity during the six months ended December 29, 2018 : Number of Shares Weighted Average Aggregate Intrinsic (1) Balance at June 30, 2018 1,079,064 Market stock units granted 247,804 Market stock units released (13,594 ) Market stock units cancelled (250,190 ) Balance at December 29, 2018 1,063,084 2.9 $ 51,889,761 Outstanding and expected to vest, December 29, 2018 960,920 2.9 $ 46,912,120 (1) Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on December 28, 2018, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of December 29, 2018. As of December 29, 2018 , there was $35.0 million of unrecognized compensation expense related to 1.1 million unvested MSUs, which is expected to be recognized over a weighted average period of approximately 2.9 years . Employee Stock Purchase Plan Employees are granted rights to acquire common stock under the 2008 ESPP. The fair value of 2008 ESPP rights granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model using the following assumptions for the offering periods outstanding: Three Months Ended Six Months Ended December 29, 2018 December 30, 2017 December 29, 2018 December 30, 2017 Expected holding period (in years) 0.5 years 0.5 years 0.5 years 0.5 years Risk-free interest rate 1.6% - 2.6% 0.8% - 1.5% 1.6% - 2.6% 0.8% - 1.5% Expected stock price volatility 19.6% - 32.7% 19.1% - 24.7% 19.6% - 32.7% 19.1% - 24.7% Dividend yield 2.1% - 3.1% 3.0% - 3.4% 2.1% - 3.1% 3.0% - 3.4% As of December 29, 2018 and December 30, 2017 , there was $8.6 million and $6.5 million , respectively, of unrecognized compensation expense related to the 2008 ESPP.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Dec. 29, 2018
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	EARNINGS (LOSS) PER SHARE Basic earnings (loss) per share are computed using the weighted average number of shares of common stock outstanding during the period. For purposes of computing basic earnings (loss) per share, the weighted average number of outstanding shares of common stock excludes unvested RSUs and other awards as well as MSUs. Diluted earnings (loss) per share incorporates the incremental shares issuable upon the assumed exercise of stock options, assumed release of unvested RSUs and other awards as well as MSUs, and assumed issuance of common stock under the 2008 ESPP using the treasury stock method. The following table sets forth the computation of basic and diluted earnings (loss) per share: Three Months Ended Six Months Ended December 29, December 30, December 29, December 30, (in thousands, except per share data) Numerator for basic earnings (loss) per share and diluted earnings (loss) per share Net income (loss) $ 131,892 $ (75,015 ) $ 329,315 $ 79,519 Denominator for basic earnings (loss) per share 276,252 281,560 277,144 281,852 Effect of dilutive securities: Stock options, ESPP, RSUs, and MSUs 3,756 — 4,270 4,503 Denominator for diluted earnings (loss) per share 280,008 281,560 281,414 286,355 Earnings (loss) per share Basic $ 0.48 $ (0.27 ) $ 1.19 $ 0.28 Diluted $ 0.47 $ (0.27 ) $ 1.17 $ 0.28 For the three months ended December 30, 2017 and December 29, 2018 , there were approximately 4.8 million and zero stock awards, respectively, that were determined to be anti-dilutive and therefore excluded from the calculation of diluted earnings per share. For the six months ended December 29, 2018 and December 30, 2017 , no stock awards were determined to be anti-dilutive and therefore none were excluded from the calculation of diluted earnings per share.

Segment Information

Segment Information	6 Months Ended
	Dec. 29, 2018
Segment Reporting [Abstract]
Segment Information [Text Block]	SEGMENT INFORMATION The Company designs, develops, manufactures and markets a broad range of linear and mixed signal integrated circuits. All of the Company's products are designed through a centralized R&D function, manufactured using centralized manufacturing (internal and external), and sold through a centralized sales force and shared wholesale distributors. one operating segment and reportable segment. In accordance with ASC No. 280, Segment Reporting (“ASC 280”) , the Company considers operating segments to be components of the Company’s business for which separate financial information is available that is evaluated regularly by the Company’s Chief Operating Decision Maker in deciding how to allocate resources and in assessing performance. The Chief Operating Decision Maker for the Company was assessed and determined to be the CEO. The CEO reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, the Company has determined that it has a single operating and reportable segment. Enterprise-wide information is provided in accordance with ASC 280. Geographical revenue information is based on customers’ ship-to location. Long-lived assets consist of property, plant and equipment. Property, plant and equipment information is based on the physical location of the assets at the end of each fiscal year. Net revenues from unaffiliated customers by geographic region were as follows: Three Months Ended Six Months Ended December 29, 2018 December 30, 2017 December 29, 2018 December 30, 2017 (in thousands) United States $ 64,845 $ 82,620 $ 136,974 $ 147,261 China 208,717 230,188 428,015 442,953 Rest of Asia 186,840 182,953 407,221 363,903 Europe 100,662 111,550 212,030 215,684 Rest of World 15,842 15,326 31,161 28,512 $ 576,906 $ 622,637 $ 1,215,401 $ 1,198,313 Net long-lived assets by geographic region were as follows: December 29, June 30, (in thousands) United States $ 358,571 $ 361,432 Philippines 111,408 120,657 Rest of World 102,004 97,275 $ 571,983 $ 579,364

Comprehensive Income Loss

Comprehensive Income Loss	6 Months Ended
	Dec. 29, 2018
Statement of Comprehensive Income [Abstract]
Comprehensive Income [Text Block]	COMPREHENSIVE INCOME (LOSS) The changes in accumulated other comprehensive income (loss) by component and related tax effects in the six months ended December 29, 2018 and December 30, 2017 were as follows: (in thousands) Unrealized Gains and Losses on Intercompany Receivables Unrealized Gains and Losses on Post-Retirement Benefits Cumulative Translation Adjustment Unrealized Gains and Losses on Cash Flow Hedges Unrealized Gains and Losses on Available-For-Sale Securities Total June 30, 2018 $ (6,280 ) $ (2,516 ) $ (1,136 ) $ (1,383 ) $ (3,670 ) $ (14,985 ) Other comprehensive income (loss) before reclassifications — — — (551 ) 2,205 1,654 Amounts reclassified out of accumulated other comprehensive loss (income) — 191 — 2,379 — 2,570 Tax effects — (37 ) — (310 ) (228 ) (575 ) Other comprehensive income (loss), net — 154 — 1,518 1,977 3,649 December 29, 2018 $ (6,280 ) $ (2,362 ) $ (1,136 ) $ 135 $ (1,693 ) $ (11,336 ) (in thousands) Unrealized Gains and Losses on Intercompany Receivables Unrealized Gains and Losses on Post-Retirement Benefits Cumulative Translation Adjustment Unrealized Gains and Losses on Cash Flow Hedges Unrealized Gains and Losses on Available-For-Sale Securities Total June 24, 2017 $ (6,280 ) $ (1,258 ) $ (1,136 ) $ 18 $ (1,234 ) $ (9,890 ) Other comprehensive income (loss) before reclassifications — — — 1,725 (2,220 ) (495 ) Amounts reclassified out of accumulated other comprehensive loss (income) — 132 — (1,324 ) — (1,192 ) Tax effects — (164 ) — (51 ) — (215 ) Other comprehensive income (loss), net — (32 ) — 350 (2,220 ) (1,902 ) December 30, 2017 $ (6,280 ) $ (1,290 ) $ (1,136 ) $ 368 $ (3,454 ) $ (11,792 )

Income Taxes

Income Taxes	6 Months Ended
	Dec. 29, 2018
Income Tax Disclosure [Abstract]
Income Taxes [Text Block]	INCOME TAXES In the three and six months ended December 29, 2018 , the Company recorded an income tax provision of $50.8 million and $87.0 million , respectively, compared to $272.9 million and $299.4 million for the three and six months ended December 30, 2017 , respectively. The Company’s effective tax rate for the three and six months ended December 29, 2018 was 27.8% and 20.9% , respectively, compared to the 137.9% and 79.0% for the three and six months ended December 30, 2017 , respectively. On December 22, 2017 legislation, commonly referred to as the Tax Cuts and Jobs Act (the “Act”), was enacted. The Act included a one-time tax on accumulated unremitted earnings of the Company's foreign subsidiaries (“Transition Tax”). SEC Staff Accounting Bulletin No. 118 allowed the use of provisional amounts (reasonable estimates) if accounting for the income tax effects of the Act was not completed. Provisional amounts must be adjusted within a one-year measurement period from the enactment date of the Act. In the second quarter of fiscal year 2018, the Company recorded a discrete $236.9 million provisional Transition Tax charge. During the measurement period, the Company gathered additional information and analyzed available guidance to more precisely compute the amount of the Transition Tax. In the second quarter of fiscal year 2019 the Company completed this work and recorded a discrete $22.1 million measurement period adjustment for the Transition Tax, which increased the Company’s effective tax rate for the three and six months ended December 29, 2018 by 12.1% and 5.3% , respectively. As of the end of the second quarter of fiscal year 2019, the accounting for income tax effects of the Act has been completed. The Act reduced the federal statutory tax rate from 35% to 21% , effective January 1, 2018, which resulted in a fiscal year 2018 federal statutory tax rate of 28.1% for the Company (average of a 35% rate for the first half of fiscal year 2018 and a 21% rate for the second half of fiscal year 2018). The Company’s federal statutory tax rate for fiscal year 2019 is 21% . In the second quarter of fiscal year 2018, the Company recorded a $13.7 million discrete charge to remeasure deferred tax assets and liabilities as of the enactment date of the Act to reflect the federal statutory tax rate reductions. The Act included Global Intangible Low-Taxed Income (“GILTI”) provisions, which impact the Company in fiscal year 2019. The GILTI provisions effectively subject income earned by the Company’s foreign subsidiaries to current U.S. tax at a rate of 10.5%, less foreign tax credits. Under U.S. GAAP, the Company can make an accounting policy election to recognize deferred taxes for temporary differences expected to impact GILTI in future years or provide for tax expense related to GILTI in the year the tax is incurred as a period expense. The Company has elected to treat tax generated by the GILTI provisions as a period expense. The Company’s federal statutory tax rate for fiscal year 2019 is 21% . The Company’s effective tax rate for the three months ended December 29, 2018 was higher than the statutory rate primarily due to a $22.1 million discrete charge for the Transition Tax, tax generated by the GILTI provisions, and a $4.9 million discrete charge for interest accruals for unrecognized tax benefits, partially offset by earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates. The Company’s effective tax rate for the six months ended December 29, 2018 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by a $22.1 million discrete charge for the Transition Tax, tax generated by the GILTI provisions, and a $9.4 million discrete charge for interest accruals for unrecognized tax benefits. The Company’s federal statutory tax rate for fiscal year 2018 was 28.1% . The Company’s effective tax rate for the three and six months ended December 30, 2017 was higher than the statutory rate primarily due to a $236.9 million discrete provisional charge for the Transition Tax, a $13.7 million discrete charge to remeasure deferred taxes as of the enactment date of the Act, $4.2 million and $8 million discrete charges for interest accruals for unrecognized tax benefits in the three and six months ended December 30, 2017 , respectively, partially offset by earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates. The Company engages in continuous discussions and negotiations with tax authorities regarding tax matters in various jurisdictions. It is reasonably possible that the balance of gross unrecognized tax benefits, including accrued interest and penalties, could decrease up to $444.0 million within the next twelve months due to the completion of federal tax audits, including any administrative appeals. The $444.0 million primarily relates to matters involving federal taxation of cross-border transactions. The Company’s federal corporate income tax returns are audited on a recurring basis by the Internal Revenue Service (“IRS”). The IRS concluded its field examination of the Company’s federal corporate income tax returns for fiscal years 2009 through 2011 and issued an IRS Revenue Agent's Report in July 2016 that included proposed adjustments for transfer pricing issues related to cost sharing and buy-in license payments for the use of intangible property by one of the Company’s international subsidiaries. The Company disagreed with the proposed transfer pricing adjustments and related penalties, and in September 2016, the Company filed a protest to challenge the proposed adjustments and request a conference with the Appeals Office of the IRS. In May 2018, a preliminary understanding was reached with the IRS regarding the contested issues for the audit and post-audit years, which the Company expects may be finalized in fiscal year 2019 with the execution of a closing agreement. In June 2018, the Company made advance payments for audit and post-audit years tax of $140.7 million and interest of $37.4 million . These payments will reduce the accrual of interest on audit and post-audit years tax deficiencies that would be owed if the preliminary understanding is finalized. The Company’s reserves for unrecognized tax benefits are sufficient to cover the audit and post-audit years tax deficiencies that would be owed as a result of the preliminary understanding. In fiscal year 2017, the IRS commenced an audit of the Company’s federal corporate income tax returns for fiscal years 2012 through 2014, which is ongoing. In the first quarter of fiscal year 2019, the Company was notified that the IRS will commence an audit of the Company's federal corporate income tax returns for fiscal years 2015 through 2016.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Dec. 29, 2018
Product Warranties Disclosures [Abstract]
Commitments and Contingencies [Text Block]	COMMITMENTS AND CONTINGENCIES Legal Proceedings The Company is party or subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, including proceedings and claims that relate to intellectual property matters. While the outcome of these matters cannot be predicted with certainty, the Company does not believe that the outcome of any of these matters, individually or in the aggregate, will result in losses that are materially in excess of amounts already recognized or reserved, if any. Indemnification The Company indemnifies certain customers, distributors, suppliers and subcontractors for attorney fees, damages and costs awarded against such parties in certain circumstances in which the Company's products are alleged to infringe third party intellectual property rights, including patents, registered trademarks or copyrights. The terms of the Company's indemnification obligations are generally perpetual from the effective date of the agreement. In certain cases, there are limits on and exceptions to the Company's potential liability for indemnification relating to intellectual property infringement claims. Pursuant to the Company's charter documents and separate written indemnification agreements, the Company has certain indemnification obligations to its current officers, employees and directors, as well as certain former officers and directors.

Common Stock Repurchases

Common Stock Repurchases	6 Months Ended
	Dec. 29, 2018
Common Stock Repurchases [Abstract]
Common Stock Repurchases [Text Block]	COMMON STOCK REPURCHASES On July 20, 2017, the board of directors of the Company authorized the repurchase of up to $1 billion of the Company's common stock. The stock repurchase authorization did not have an expiration date and the pace of repurchase activity depended on factors such as current stock price, levels of cash generation from operations, cash requirements, and other factors. All prior repurchase authorizations by the Company’s board of directors for the repurchase of common stock were cancelled and superseded by this repurchase authorization. On October 30, 2018, the board of directors of the Company authorized the repurchase of up to $ 1.5 billion of the Company’s common stock. The stock repurchase authorization does not have an expiration date and the pace of repurchase activity will depend on factors such as current stock price, levels of cash generation from operations, cash requirements, and other factors. All prior repurchase authorizations by the Company’s board of directors for the repurchase of common stock were cancelled and superseded by this repurchase authorization. During the six months ended December 29, 2018 , the Company repurchased approximately 5.8 million shares of its common stock for $320.1 million . As of December 29, 2018 , the Company had remaining authorization of $1.3 billion for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company’s common stock and general market and business conditions.

Acquisitions (Notes)

Acquisitions (Notes)	6 Months Ended
	Dec. 29, 2018
Business Combinations [Abstract]
Business Combination Disclosure [Text Block]	ACQUISITION On January 26, 2018, the Company acquired a privately-held corporation specializing in the development of high-performance USB and video extension technology. Total cash consideration paid in connection with this acquisition was $57.8 million , net of cash acquired. The Company also agreed to pay up to an additional $16.0 million if the acquired business achieves certain financial milestones for the annual period ended August 31, 2018 and annual period ending August 31, 2019. Out of the $16.0 million , $8.0 million was paid during the six months ended December 29, 2018 . The acquired assets included $26.0 million of developed technology and $10.5 million of other intangible assets. The Company also recorded $41.9 million of goodwill in connection with this acquisition. The goodwill is not deductible for tax purposes.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
	Dec. 29, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets [Text Block]	GOODWILL AND INTANGIBLE ASSETS Goodwill The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable. There were no changes to goodwill for the six months ended December 29, 2018 . No indicators or instances of impairment were identified in the six months and fiscal year ended December 29, 2018 and June 30, 2018 , respectively. Intangible assets consisted of the following: December 29, June 30, Original Cost Accumulated Amortization Net Original Cost Accumulated Amortization Net (in thousands) Intellectual property $ 488,846 $ 437,652 $ 51,194 $ 485,465 $ 423,869 $ 61,596 Customer relationships 116,505 104,557 11,948 116,294 103,217 13,077 Trade name 9,974 8,745 1,229 9,340 8,588 752 Patents 2,500 2,500 — 2,500 2,469 31 Total amortizable purchased intangible assets 617,825 553,454 64,371 613,599 538,143 75,456 IPR&D 2,790 — 2,790 2,790 — 2,790 Total purchased intangible assets $ 620,615 $ 553,454 $ 67,161 $ 616,389 $ 538,143 $ 78,246 The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income: Three Months Ended Six Months Ended December 29, December 30, December 29, December 30, (in thousands) Cost of goods sold $ 6,868 $ 11,140 $ 13,783 $ 22,204 Intangible asset amortization 756 995 1,529 2,747 Total intangible asset amortization expenses $ 7,624 $ 12,135 $ 15,312 $ 24,951 The following table represents the estimated future amortization expense of intangible assets as of December 29, 2018 : Fiscal Year Amount (in thousands) Remaining six months of 2019 $ 10,918 2020 15,068 2021 13,368 2022 7,689 2023 7,205 Thereafter 10,123 Total intangible assets $ 64,371

Recently Issued Accounting Pr_2

Recently Issued Accounting Pronouncements Cumulative effect of the changes to the condensed consolidated balance sheet from the adoption of Topic 606 (Tables)	6 Months Ended
	Dec. 29, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Schedule of Prospective Adoption of New Accounting Pronouncements [Table Text Block]	The following table summarizes the impacts of adopting Topic 606 on the Company’s Condensed Consolidated Balance Sheet as of December 29, 2018 (in thousands): As Reported If Reported Under Topic 605 Effect of Adoption of Topic 606 Accounts receivable, net $ 391,419 $ 260,818 $ 130,601 Price adjustment and other revenue reserves 130,601 — 130,601
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]	The cumulative effect of the changes to the condensed consolidated balance sheet from the adoption of Topic 606 was as follows (in thousands): As of June 30, 2018 Effect of Adoption of Topic 606 As of July 1, 2018 Accounts receivable, net $ 280,072 $ 141,652 $ 421,724 Price adjustment and other revenue reserves — 141,652 141,652

Balance Sheet Components (Table

Balance Sheet Components (Tables)	6 Months Ended
	Dec. 29, 2018
Balance Sheet Related Disclosures [Abstract]
Schedule of Inventory, Current [Table Text Block]	Inventories consist of: December 29, June 30, Inventories: (in thousands) Raw materials $ 16,832 $ 16,251 Work-in-process 171,287 173,859 Finished goods 90,806 92,280 $ 278,925 $ 282,390
Property, Plant and Equipment [Table Text Block]	Property, plant and equipment, net consists of: December 29, June 30, Property, plant and equipment, net: (in thousands) Land $ 17,731 $ 17,731 Buildings and building improvements 258,679 254,733 Machinery, equipment and software 1,339,552 1,309,487 1,615,962 1,581,951 Less: accumulated depreciation (1,043,979 ) (1,002,587 ) $ 571,983 $ 579,364
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	Accrued salary and related expenses consist of: December 29, June 30, Accrued salary and related expenses: (in thousands) Accrued vacation $ 31,914 $ 30,695 Accrued bonus 43,511 92,288 Accrued salaries 8,616 8,210 ESPP withholding 4,267 5,158 Accrued fringe benefits 8,279 4,752 Other 5,840 10,579 $ 102,427 $ 151,682

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Dec. 29, 2018
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Assets and liabilities measured at fair value on a recurring basis were as follows: As of December 29, 2018 As of June 30, 2018 Fair Value Measurements Using Total Fair Value Measurements Using Total Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 (in thousands) Assets Cash and cash equivalents Agency securities $ — $ — $ — $ — $ — $ 13,946 $ — $ 13,946 Certificates of deposit — 1,000 — 1,000 — 6,000 — 6,000 Commercial paper — — — — — 45,063 — 45,063 Corporate debt securities — — — — — 3,819 — 3,819 Money market funds 167,698 — — 167,698 98,467 — — 98,467 U.S. Treasury securities — — — — — 30,988 — 30,988 Short term investments Certificates of deposit — 34,997 — 34,997 — 52,428 — 52,428 Commercial paper — 38,437 — 38,437 — 64,354 — 64,354 Corporate debt securities — 263,562 — 263,562 — 367,765 — 367,765 U.S. Treasury securities — 216,905 — 216,905 — 598,368 — 598,368 Other current assets Foreign currency forward contracts — 418 — 418 — 235 — 235 Total assets $ 167,698 $ 555,319 $ — $ 723,017 $ 98,467 $ 1,182,966 $ — $ 1,281,433 Liabilities Accrued expenses Foreign currency forward contracts $ — $ 270 $ — $ 270 $ — $ 1,845 $ — $ 1,845 Contingent consideration — — 9,052 9,052 — — 8,000 8,000 Other liabilities Contingent consideration — — 1,052 1,052 — — 8,000 8,000 Total Liabilities $ — $ 270 $ 10,104 $ 10,374 $ — $ 1,845 $ 16,000 $ 17,845

Financial Instruments (Tables)

Financial Instruments (Tables)	6 Months Ended
	Dec. 29, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments, Gain (Loss) [Table Text Block]	The following table summarizes the gains (losses) from hedging activities recognized in the Company's Condensed Consolidated Statements of Income: Three Months Ended Six Months Ended December 29, 2018 December 29, 2018 Net Revenue Cost of Goods Sold Operating Expenses Net Revenue Cost of Goods Sold Operating Expenses (in thousands) Income and expenses line items in which the effects of cash flow hedges are recorded $ 576,906 $ 203,858 $ 190,844 $ 1,215,401 $ 412,117 $ 386,898 Gain (loss) on cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income $ 5 $ (82 ) $ (602 ) $ 44 (596 ) (1,827 )
Available-for-sale investments [Table Text Block]	Fair values were as follows: December 29, June 30, Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value (in thousands) Available-for-sale investments Certificates of deposit $ 34,997 $ — $ — $ 34,997 $ 52,429 $ — $ (1 ) $ 52,428 Commercial paper 38,437 — — 38,437 64,354 — — 64,354 Corporate debt securities 264,880 — (1,318 ) 263,562 369,734 39 (2,008 ) 367,765 U.S. Treasury securities 217,280 1 (376 ) 216,905 600,068 10 (1,710 ) 598,368 Total available-for-sale investments $ 555,594 $ 1 $ (1,694 ) $ 553,901 $ 1,086,585 $ 49 $ (3,719 ) $ 1,082,915
Schedule of long-term debt [Table Text Block]	The following table summarizes the Company’s outstanding debt obligations: December 29, 2018 June 30, 2018 (in thousands) 3.45% fixed rate notes due June 2027 $ 500,000 $ 500,000 2.5% fixed rate notes due November 2018 — 500,000 3.375% fixed rate notes due March 2023 500,000 500,000 Total outstanding debt 1,000,000 1,500,000 Less: Current portion (included in "Current portion of debt") — (499,406 ) Less: Reduction for unamortized discount and debt issuance costs (8,134 ) (9,447 ) Total long-term debt $ 991,866 $ 991,147
Financial Instruments [Text Block]	FINANCIAL INSTRUMENTS Short-term investments Fair values were as follows: December 29, June 30, Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value (in thousands) Available-for-sale investments Certificates of deposit $ 34,997 $ — $ — $ 34,997 $ 52,429 $ — $ (1 ) $ 52,428 Commercial paper 38,437 — — 38,437 64,354 — — 64,354 Corporate debt securities 264,880 — (1,318 ) 263,562 369,734 39 (2,008 ) 367,765 U.S. Treasury securities 217,280 1 (376 ) 216,905 600,068 10 (1,710 ) 598,368 Total available-for-sale investments $ 555,594 $ 1 $ (1,694 ) $ 553,901 $ 1,086,585 $ 49 $ (3,719 ) $ 1,082,915 In the three and six months ended December 29, 2018 and June 30, 2018 , the Company did not recognize any impairment charges on short-term investments. All available-for-sale investments have maturity dates between December 29, 2018 and March 12, 2021. The Company invests in various financial instruments including U.S. Treasury securities, corporate debt securities, commercial paper, and certificates of deposit which include instruments issued or managed by industrial, financial, and utility institutions and U.S. Treasury securities which include U.S. government Treasury bills and Treasury notes. Derivative instruments and hedging activities The Company incurs expenditures denominated in non-U.S. currencies, primarily the Philippine Peso and the Thai Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and the European Euro, Indian Rupee, Japanese Yen, Taiwan New Dollar, South Korean Won, Chinese Yuan and Canadian Dollar, for sales offices and research and development activities undertaken outside of the U.S. The Company has established a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures. The Company does not use these foreign currency forward contracts for trading purposes. Derivatives designated as cash flow hedging instruments The Company designates certain forward contracts as hedging instruments pursuant to Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging (“ASC 815”). As of December 29, 2018 and June 30, 2018 , the notional amounts of the forward contracts the Company held to purchase international currencies were $42.2 million and $49.7 million , respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $0.3 million and $1.2 million , respectively. Derivatives not designated as hedging instruments As of December 29, 2018 and June 30, 2018 , the notional amounts of the forward contracts the Company held to purchase international currencies were $19.8 million and $21.1 million , respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $19.0 million and $21.3 million , respectively. The fair values of the Company's outstanding foreign currency forward contracts and gain (loss) included in the Condensed Consolidated Statements of Income were not material for the three and six months ended December 29, 2018 and December 30, 2017 . Effect of hedge accounting on the Condensed Consolidated Statements of Income The following table summarizes the gains (losses) from hedging activities recognized in the Company's Condensed Consolidated Statements of Income: Three Months Ended Six Months Ended December 29, 2018 December 29, 2018 Net Revenue Cost of Goods Sold Operating Expenses Net Revenue Cost of Goods Sold Operating Expenses (in thousands) Income and expenses line items in which the effects of cash flow hedges are recorded $ 576,906 $ 203,858 $ 190,844 $ 1,215,401 $ 412,117 $ 386,898 Gain (loss) on cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income $ 5 $ (82 ) $ (602 ) $ 44 (596 ) (1,827 ) Outstanding debt obligations The following table summarizes the Company’s outstanding debt obligations: December 29, 2018 June 30, 2018 (in thousands) 3.45% fixed rate notes due June 2027 $ 500,000 $ 500,000 2.5% fixed rate notes due November 2018 — 500,000 3.375% fixed rate notes due March 2023 500,000 500,000 Total outstanding debt 1,000,000 1,500,000 Less: Current portion (included in "Current portion of debt") — (499,406 ) Less: Reduction for unamortized discount and debt issuance costs (8,134 ) (9,447 ) Total long-term debt $ 991,866 $ 991,147 On June 15, 2017, the Company completed a public offering of $500 million aggregate principal amount of the Company's 3.45% senior unsecured and unsubordinated notes due in June 2027 (“2027 Notes”), with an effective interest rate of 3.5% . Interest on the 2027 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, commencing on December 15, 2017. The net proceeds of this offering were approximately $495.2 million , after issuing at a discount and deducting paid expenses. On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% coupon senior unsecured and unsubordinated notes due in November 2018 (“2018 Notes”), with an effective interest rate of 2.6% . Interest on the 2018 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing on May 15, 2014. The net proceeds of this offering were approximately $494.5 million , after issuing at a discount and deducting paid expenses. In November of 2018, the Company repaid the entire $500 million in principal and any outstanding interest, related to these outstanding notes. On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 3.375% senior unsecured and unsubordinated notes due in March 2023 (“2023 Notes”), with an effective interest rate of 3.5% . Interest on the 2023 Notes is payable semi-annually in arrears on March 15 and September 15 of each year. The net proceeds of this offering were approximately $490.0 million , after issuing at a discount and deducting paid expenses. The debt indentures that govern the 2027 Notes and the 2023 Notes include covenants that limit the Company's ability to grant liens on its facilities and to enter into sale and leaseback transactions, which could limit the Company's ability to secure additional debt funding in the future. In circumstances involving a change of control of the Company followed by a downgrade of the rating of the 2027 Notes or the 2023 Notes, the Company would be required to make an offer to repurchase the affected notes at a purchase price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest. The Company accounts for all the notes above based on their amortized cost. The discount and expenses are being amortized to Interest and other income (expense), net in the Condensed Consolidated Statements of Income over the life of the notes. The interest expense is recorded in Interest and other income (expense), net in the Condensed Consolidated Statements of Income. Amortized discount and expenses, as well as interest expense associated with the notes, were $11.2 million and $12.4 million during the three months ended December 29, 2018 and December 30, 2017 , respectively. Amortized discount and expenses, as well as interest expense associated with the notes, were $23.6 million and $24.7 million , respectively, during the six months ended December 29, 2018 and December 30, 2017 . The estimated fair value of the Company’s outstanding debt obligations was approximately $955 million as of December 29, 2018 . The estimated fair value of the debt is based primarily on observable market inputs and is a Level 2 measurement. The Company recorded interest expense of $11.7 million and $12.5 million during the three months ended December 29, 2018 , and December 30, 2017 , respectively. The Company recorded interest expense of $24.6 million and $25.1 million during the six months ended December 29, 2018 and December 30, 2017 , respectively. Credit Facility Revolving credit facility As of December 29, 2018, the Company had access to a $350 million senior unsecured revolving credit facility with certain institutional lenders that expires on June 27, 2019. The facility fee is at a rate per annum that varies based on the Company’s index debt rating and any advances under the credit agreement will accrue interest at a base rate plus a margin based on the Company’s index debt rating. The credit agreement required the Company to comply with certain covenants, including a requirement that the Company maintain a ratio of debt to EBITDA (earnings before interest, taxes, depreciation, and amortization) of not more than 3 to 1 and a minimum interest coverage ratio (EBITDA divided by interest expense) greater than 3.5 to 1 . As of December 29, 2018 , the Company had not borrowed any amounts from this credit facility and was in compliance with all debt covenants. Effective January 22, 2019, the Company terminated this revolving credit facility. Other Financial Instruments For the balance of the Company’s financial instruments, cash equivalents, accounts receivable, accounts payable and other accrued liabilities, the carrying amounts approximate fair value due to their short maturities.

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Dec. 29, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	The following tables show total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and six months ended December 29, 2018 and December 30, 2017 , respectively: Three Months Ended December 29, 2018 December 30, 2017 Stock Options Restricted Stock Units Employee Stock Purchase Plan Total Stock Options Restricted Stock Units Employee Stock Purchase Plan Total (in thousands) Cost of goods sold $ 9 $ 1,884 $ 495 $ 2,388 $ 75 $ 1,944 $ 467 $ 2,486 Research and development 11 8,693 1,135 9,839 185 8,898 1,033 10,116 Selling, general and administrative 58 8,773 598 9,429 222 7,656 558 8,436 Pre-tax stock-based compensation expense $ 78 $ 19,350 $ 2,228 $ 21,656 $ 482 $ 18,498 $ 2,058 $ 21,038 Less: income tax effect 2,304 1,887 Net stock-based compensation expense $ 19,352 $ 19,151 Six Months Ended December 29, 2018 December 30, 2017 Stock Options Restricted Stock Units Employee Stock Purchase Plan Total Stock Options Restricted Stock Units Employee Stock Purchase Plan Total (in thousands) Cost of goods sold $ 19 $ 3,646 $ 1,002 $ 4,667 $ 161 $ 3,780 $ 946 $ 4,887 Research and development 22 17,384 2,290 19,696 493 15,487 2,003 17,983 Selling, general and administrative 114 16,417 1,259 17,790 585 13,786 1,086 15,457 Pre-tax stock-based compensation expense $ 155 $ 37,447 $ 4,551 $ 42,153 $ 1,239 $ 33,053 $ 4,035 $ 38,327 Less: income tax effect 4,268 4,777 Net stock-based compensation expense $ 37,885 $ 33,550
Share-based Compensation Arrangements by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of December 29, 2018 and related activity for the six months ended December 29, 2018 : Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (in Years) Aggregate Intrinsic Value (1) Balance at June 30, 2018 1,688,253 $ 27.72 Options Granted — Options Exercised (522,499 ) 26.96 Options Cancelled (3,439 ) 28.08 Balance at December 29, 2018 1,162,315 $ 28.06 1.5 $ 24,126,273 Exercisable, December 29, 2018 1,162,315 $ 28.06 1.5 $ 24,126,273 Vested and expected to vest, December 29, 2018 1,162,315 $ 28.06 1.5 $ 24,126,273 (1) Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on December 28, 2018, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of December 29, 2018.
Share-based Compensation Arrangements by Share-based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block]	The following table summarizes the outstanding and expected to vest RSUs and other awards as of December 29, 2018 and related activity during the six months ended December 29, 2018 : Number of Shares Weighted Average Aggregate Intrinsic Value (1) Balance at June 30, 2018 5,524,432 Restricted stock units and other awards granted 1,321,125 Restricted stock units and other awards released (802,916 ) Restricted stock units and other awards cancelled (325,807 ) Balance at December 29, 2018 5,716,834 2.9 $ 279,095,836 Outstanding and expected to vest, December 29, 2018 4,743,351 2.8 $ 231,570,395 (1) Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on December 28, 2018, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of December 29, 2018.
Share-based Compensation Arrangements by Share-based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]	The following table summarizes the number of MSUs outstanding and expected to vest as of December 29, 2018 and their activity during the six months ended December 29, 2018 : Number of Shares Weighted Average Aggregate Intrinsic (1) Balance at June 30, 2018 1,079,064 Market stock units granted 247,804 Market stock units released (13,594 ) Market stock units cancelled (250,190 ) Balance at December 29, 2018 1,063,084 2.9 $ 51,889,761 Outstanding and expected to vest, December 29, 2018 960,920 2.9 $ 46,912,120 (1) Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on December 28, 2018, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of December 29, 2018.
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]	The fair value of 2008 ESPP rights granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model using the following assumptions for the offering periods outstanding: Three Months Ended Six Months Ended December 29, 2018 December 30, 2017 December 29, 2018 December 30, 2017 Expected holding period (in years) 0.5 years 0.5 years 0.5 years 0.5 years Risk-free interest rate 1.6% - 2.6% 0.8% - 1.5% 1.6% - 2.6% 0.8% - 1.5% Expected stock price volatility 19.6% - 32.7% 19.1% - 24.7% 19.6% - 32.7% 19.1% - 24.7% Dividend yield 2.1% - 3.1% 3.0% - 3.4% 2.1% - 3.1% 3.0% - 3.4%

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Dec. 29, 2018
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following table sets forth the computation of basic and diluted earnings (loss) per share: Three Months Ended Six Months Ended December 29, December 30, December 29, December 30, (in thousands, except per share data) Numerator for basic earnings (loss) per share and diluted earnings (loss) per share Net income (loss) $ 131,892 $ (75,015 ) $ 329,315 $ 79,519 Denominator for basic earnings (loss) per share 276,252 281,560 277,144 281,852 Effect of dilutive securities: Stock options, ESPP, RSUs, and MSUs 3,756 — 4,270 4,503 Denominator for diluted earnings (loss) per share 280,008 281,560 281,414 286,355 Earnings (loss) per share Basic $ 0.48 $ (0.27 ) $ 1.19 $ 0.28 Diluted $ 0.47 $ (0.27 ) $ 1.17 $ 0.28

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Dec. 29, 2018
Segment Reporting [Abstract]
Schedule of Revenue from External Customers by Geographical Areas [Table Text Block]	Net revenues from unaffiliated customers by geographic region were as follows: Three Months Ended Six Months Ended December 29, 2018 December 30, 2017 December 29, 2018 December 30, 2017 (in thousands) United States $ 64,845 $ 82,620 $ 136,974 $ 147,261 China 208,717 230,188 428,015 442,953 Rest of Asia 186,840 182,953 407,221 363,903 Europe 100,662 111,550 212,030 215,684 Rest of World 15,842 15,326 31,161 28,512 $ 576,906 $ 622,637 $ 1,215,401 $ 1,198,313
Schedule of Long Lived Assets by Geographical Areas [Table Text Block]	Net long-lived assets by geographic region were as follows: December 29, June 30, (in thousands) United States $ 358,571 $ 361,432 Philippines 111,408 120,657 Rest of World 102,004 97,275 $ 571,983 $ 579,364

Comprehensive Income Loss (Tabl

Comprehensive Income Loss (Tables)	6 Months Ended
	Dec. 29, 2018
Statement of Comprehensive Income [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	The changes in accumulated other comprehensive income (loss) by component and related tax effects in the six months ended December 29, 2018 and December 30, 2017 were as follows: (in thousands) Unrealized Gains and Losses on Intercompany Receivables Unrealized Gains and Losses on Post-Retirement Benefits Cumulative Translation Adjustment Unrealized Gains and Losses on Cash Flow Hedges Unrealized Gains and Losses on Available-For-Sale Securities Total June 30, 2018 $ (6,280 ) $ (2,516 ) $ (1,136 ) $ (1,383 ) $ (3,670 ) $ (14,985 ) Other comprehensive income (loss) before reclassifications — — — (551 ) 2,205 1,654 Amounts reclassified out of accumulated other comprehensive loss (income) — 191 — 2,379 — 2,570 Tax effects — (37 ) — (310 ) (228 ) (575 ) Other comprehensive income (loss), net — 154 — 1,518 1,977 3,649 December 29, 2018 $ (6,280 ) $ (2,362 ) $ (1,136 ) $ 135 $ (1,693 ) $ (11,336 ) (in thousands) Unrealized Gains and Losses on Intercompany Receivables Unrealized Gains and Losses on Post-Retirement Benefits Cumulative Translation Adjustment Unrealized Gains and Losses on Cash Flow Hedges Unrealized Gains and Losses on Available-For-Sale Securities Total June 24, 2017 $ (6,280 ) $ (1,258 ) $ (1,136 ) $ 18 $ (1,234 ) $ (9,890 ) Other comprehensive income (loss) before reclassifications — — — 1,725 (2,220 ) (495 ) Amounts reclassified out of accumulated other comprehensive loss (income) — 132 — (1,324 ) — (1,192 ) Tax effects — (164 ) — (51 ) — (215 ) Other comprehensive income (loss), net — (32 ) — 350 (2,220 ) (1,902 ) December 30, 2017 $ (6,280 ) $ (1,290 ) $ (1,136 ) $ 368 $ (3,454 ) $ (11,792 )

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Goodwill [Line Items]
Goodwill and Intangible Assets Disclosure [Text Block]	GOODWILL AND INTANGIBLE ASSETS Goodwill The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable. There were no changes to goodwill for the six months ended December 29, 2018 . No indicators or instances of impairment were identified in the six months and fiscal year ended December 29, 2018 and June 30, 2018 , respectively. Intangible assets consisted of the following: December 29, June 30, Original Cost Accumulated Amortization Net Original Cost Accumulated Amortization Net (in thousands) Intellectual property $ 488,846 $ 437,652 $ 51,194 $ 485,465 $ 423,869 $ 61,596 Customer relationships 116,505 104,557 11,948 116,294 103,217 13,077 Trade name 9,974 8,745 1,229 9,340 8,588 752 Patents 2,500 2,500 — 2,500 2,469 31 Total amortizable purchased intangible assets 617,825 553,454 64,371 613,599 538,143 75,456 IPR&D 2,790 — 2,790 2,790 — 2,790 Total purchased intangible assets $ 620,615 $ 553,454 $ 67,161 $ 616,389 $ 538,143 $ 78,246 The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income: Three Months Ended Six Months Ended December 29, December 30, December 29, December 30, (in thousands) Cost of goods sold $ 6,868 $ 11,140 $ 13,783 $ 22,204 Intangible asset amortization 756 995 1,529 2,747 Total intangible asset amortization expenses $ 7,624 $ 12,135 $ 15,312 $ 24,951 The following table represents the estimated future amortization expense of intangible assets as of December 29, 2018 : Fiscal Year Amount (in thousands) Remaining six months of 2019 $ 10,918 2020 15,068 2021 13,368 2022 7,689 2023 7,205 Thereafter 10,123 Total intangible assets $ 64,371
Schedule of Goodwill [Table Text Block]	The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable. There were no changes to goodwill for the six months ended December 29, 2018 . No indicators or instances of impairment were identified in the six months and fiscal year ended December 29, 2018 and June 30, 2018 , respectively. Intangible assets consisted of the following: December 29, June 30, Original Cost Accumulated Amortization Net Original Cost Accumulated Amortization Net (in thousands) Intellectual property $ 488,846 $ 437,652 $ 51,194 $ 485,465 $ 423,869 $ 61,596 Customer relationships 116,505 104,557 11,948 116,294 103,217 13,077 Trade name 9,974 8,745 1,229 9,340 8,588 752 Patents 2,500 2,500 — 2,500 2,469 31 Total amortizable purchased intangible assets 617,825 553,454 64,371 613,599 538,143 75,456 IPR&D 2,790 — 2,790 2,790 — 2,790 Total purchased intangible assets $ 620,615 $ 553,454 $ 67,161 $ 616,389 $ 538,143 $ 78,246
Schedule of intangible assets [Table Text Block]	Intangible assets consisted of the following: December 29, June 30, Original Cost Accumulated Amortization Net Original Cost Accumulated Amortization Net (in thousands) Intellectual property $ 488,846 $ 437,652 $ 51,194 $ 485,465 $ 423,869 $ 61,596 Customer relationships 116,505 104,557 11,948 116,294 103,217 13,077 Trade name 9,974 8,745 1,229 9,340 8,588 752 Patents 2,500 2,500 — 2,500 2,469 31 Total amortizable purchased intangible assets 617,825 553,454 64,371 613,599 538,143 75,456 IPR&D 2,790 — 2,790 2,790 — 2,790 Total purchased intangible assets $ 620,615 $ 553,454 $ 67,161 $ 616,389 $ 538,143 $ 78,246
Schedule of amortization expense allocation of intangible assets [Table Text Block]		The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income: Three Months Ended Six Months Ended December 29, December 30, December 29, December 30, (in thousands) Cost of goods sold $ 6,868 $ 11,140 $ 13,783 $ 22,204 Intangible asset amortization 756 995 1,529 2,747 Total intangible asset amortization expenses $ 7,624 $ 12,135 $ 15,312 $ 24,951
Estimated future amortization expense of intangible assets [Table Text Block]	The following table represents the estimated future amortization expense of intangible assets as of December 29, 2018 : Fiscal Year Amount (in thousands) Remaining six months of 2019 $ 10,918 2020 15,068 2021 13,368 2022 7,689 2023 7,205 Thereafter 10,123 Total intangible assets $ 64,371

Recently Issued Accounting Pr_3

Recently Issued Accounting Pronouncements (Details) - USD ($)	3 Months Ended	6 Months Ended
	Dec. 29, 2018	Dec. 29, 2018	Dec. 30, 2017	Jul. 01, 2018	Jun. 30, 2018
New Accounting Pronouncement, Early Adoption [Line Items]
Accounts Receivable, Net, Current	$ 391,419,000	$ 391,419,000			$ 280,072,000
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]		The cumulative effect of the changes to the condensed consolidated balance sheet from the adoption of Topic 606 was as follows (in thousands): As of June 30, 2018 Effect of Adoption of Topic 606 As of July 1, 2018 Accounts receivable, net $ 280,072 $ 141,652 $ 421,724 Price adjustment and other revenue reserves — 141,652 141,652
Cash flow from operating activities operating activities		$ 431,435,000	$ 449,580,000
Accounts Receivable, Net				$ 421,724,000	$ 280,072,000
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	130,601,000
Adjustments for New Accounting Pronouncement [Member]
New Accounting Pronouncement, Early Adoption [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	141,652,000
Accounting Standards Update 2014-09 [Member]
New Accounting Pronouncement, Early Adoption [Line Items]
Accounts Receivable, Net, Current	$ 260,818,000	$ 260,818,000

Recently Issued Accounting Pr_4

Recently Issued Accounting Pronouncements Schedule of prospective adoption of new accounting pronouncements (Details)	3 Months Ended
	Dec. 29, 2018USD ($)
Item Effected [Line Items]
Income Tax Effects Allocated Directly to Equity, Prior Period Adjustment	$ 2,500,000
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	130,601,000
Adjustments for New Accounting Pronouncement [Member]
Item Effected [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	$ 141,652,000

Balance Sheet Components (Detai

Balance Sheet Components (Details) - USD ($) $ in Thousands	Dec. 29, 2018	Jun. 30, 2018
Inventories:
Raw materials	$ 16,832	$ 16,251
Work-in-process	171,287	173,859
Finished goods	90,806	92,280
Inventory, net	278,925	282,390
Property, plant and equipment:
Land	17,731	17,731
Buildings and building improvements	258,679	254,733
Machinery and equipment	1,339,552	1,309,487
Property, plant and equipment, gross	1,615,962	1,581,951
Less: accumulated depreciation and amortization	(1,043,979)	(1,002,587)
Property, plant and equipment, net	571,983	579,364
Employee-related Liabilities, Current [Abstract]
Accrued Vacation	31,914	30,695
Accrued Bonuses	43,511	92,288
Accrued Salaries	8,616	8,210
Accrued Employee Stock Purchase Program Withholding	4,267	5,158
Accrued Employee Benefits	8,279	4,752
Other	5,840	10,579
Accrued salary and related expenses	$ 102,427	$ 151,682

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 29, 2018	Dec. 30, 2017	Jun. 30, 2018	Mar. 31, 2018	Jun. 24, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Impairment Charges	$ 753	$ 850	$ 753	$ 892	$ 900
Interest Expense, Debt	11,200	12,400	23,600	24,700
Cash and cash equivalents	1,406,740	$ 1,631,510	1,406,740	$ 1,631,510	1,543,484		$ 2,246,121
Available-for-sale Securities					1,082,915
Business Combination, Contingent Consideration, Liability					8,000	$ 16,000
Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets	723,017		723,017		1,281,433
Total Liabilities	10,374		10,374		17,845
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets	167,698		167,698		98,467
Total Liabilities	0		0		0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets	555,319		555,319		1,182,966
Total Liabilities	270		270		1,845
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets	0		0		0
Total Liabilities	10,104		10,104		16,000
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	167,698		167,698		98,467
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	167,698		167,698		98,467
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents					0
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents					0
Commercial paper | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		45,063
Available-for-sale Securities	38,437		38,437		64,354
Commercial paper | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		45,063
Available-for-sale Securities	38,437		38,437		64,354
Corporate debt securities | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		3,819
Available-for-sale Securities	263,562		263,562		367,765
Corporate debt securities | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		3,819
Available-for-sale Securities	263,562		263,562		367,765
US Treasury Securities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0		0		30,988
Available-for-sale Securities	216,905		216,905		598,368
US Treasury Securities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities					0
US Treasury Securities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		30,988
Available-for-sale Securities	216,905		216,905		598,368
US Treasury Securities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities					0
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts	418		418		235
Foreign currency forward contracts	270		270		1,845
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts					0
Foreign currency forward contracts	0		0		0
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts	418		418		235
Foreign currency forward contracts	270		270		1,845
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts					0
Foreign currency forward contracts	0		0		0
Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability	9,052		9,052		8,000
Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability	9,052		9,052
Certificates of deposit | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	1,000		1,000		6,000
Available-for-sale Securities	34,997		34,997		52,428
Certificates of deposit | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	1,000		1,000		6,000
Available-for-sale Securities	34,997		34,997		52,428
Agency Securities | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		13,946
Agency Securities | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		0
Agency Securities | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		13,946
Agency Securities | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		0
Other Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability	1,052		1,052		8,000
Other Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability	$ 1,052		$ 1,052		$ 8,000

Financial Instruments, Short-te

Financial Instruments, Short-term Investments (Details) - USD ($) $ in Thousands	Dec. 29, 2018	Jun. 30, 2018
Debt Securities, Available-for-sale [Abstract]
Estimated Fair Value		$ 1,082,915
Debt Securities, Available-for-sale, Amortized Cost	$ 555,594	1,086,585
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	1	49
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	1,694	3,719
Debt Securities, Available-for-sale	553,901
Certificates of deposit
Debt Securities, Available-for-sale [Abstract]
Debt Securities, Available-for-sale, Amortized Cost	34,997	52,429
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	0	1
Debt Securities, Available-for-sale	34,997	52,428
Commercial paper
Debt Securities, Available-for-sale [Abstract]
Debt Securities, Available-for-sale, Amortized Cost	38,437	64,354
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax		0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax		0
Debt Securities, Available-for-sale	38,437	64,354
Corporate debt securities
Debt Securities, Available-for-sale [Abstract]
Debt Securities, Available-for-sale, Amortized Cost	264,880	369,734
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0	39
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	1,318	2,008
Debt Securities, Available-for-sale	263,562	367,765
U.S. Treasury securities
Debt Securities, Available-for-sale [Abstract]
Debt Securities, Available-for-sale, Amortized Cost	217,280	600,068
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	1	10
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	376	1,710
Debt Securities, Available-for-sale	$ 216,905	$ 598,368

Financial Instruments Financial

Financial Instruments Financial Instruments, Securities Received as Consideration (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Jun. 30, 2018
Investment [Line Items]
Proceeds from sale of shares	$ 27,253	$ 39,996
Estimated Fair Value			$ 1,082,915
Not Designated as Hedging Instrument [Member] | Forward contracts held to purchase U.S. dollars [Member]
Investment [Line Items]
Derivative, Notional Amount	19,800		21,100
Not Designated as Hedging Instrument [Member] | Forward contracts held to sell U.S. dollars [Member]
Investment [Line Items]
Derivative, Notional Amount	19,000		21,300
Designated as Hedging Instrument [Member] | Forward contracts held to purchase U.S. dollars [Member] | Cash Flow Hedging [Member]
Investment [Line Items]
Derivative, Notional Amount	42,200		49,700
Designated as Hedging Instrument [Member] | Forward contracts held to sell U.S. dollars [Member] | Cash Flow Hedging [Member]
Investment [Line Items]
Derivative, Notional Amount	$ 300		$ 1,200

Financial Instruments, Balance

Financial Instruments, Balance Sheet Location (Details) - USD ($) $ in Millions	Dec. 29, 2018	Jun. 30, 2018
Derivatives designated as hedging instruments [Member] | Cash Flow Hedging [Member] | Forward contracts held to purchase U.S. dollars [Member]
Derivatives, Fair Value [Line Items]
Notional amount of derivatives	$ 42.2	$ 49.7
Derivatives designated as hedging instruments [Member] | Cash Flow Hedging [Member] | Forward contracts held to sell U.S. dollars [Member]
Derivatives, Fair Value [Line Items]
Notional amount of derivatives	0.3	1.2
Derivatives not designated as hedging instruments [Member] | Forward contracts held to purchase U.S. dollars [Member]
Derivatives, Fair Value [Line Items]
Notional amount of derivatives	19.8	21.1
Derivatives not designated as hedging instruments [Member] | Forward contracts held to sell U.S. dollars [Member]
Derivatives, Fair Value [Line Items]
Notional amount of derivatives	$ 19	$ 21.3

Financial Instruments, Long-ter

Financial Instruments, Long-term Debt (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 29, 2018	Dec. 30, 2017	Jun. 30, 2018	Jun. 24, 2017	Mar. 31, 2018	Dec. 28, 2013	Mar. 30, 2013
Debt Instrument [Line Items]
Debt, Long-term and Short-term, Combined Amount	$ 1,000,000		$ 1,000,000		$ 1,500,000
Short-term Debt	0		0		(499,406)
Amortization of Debt Issuance Costs	(8,134)				(9,447)
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed						101.00%
Interest expense relating to the Notes	11,200	$ 12,400	23,600	$ 24,700
Estimated fair value of long-term debt	955,000		955,000
Interest Expense	11,700	$ 12,500	24,600	$ 25,100
Secured Long-term Debt, Noncurrent	991,866		991,866		991,147
Fixed Rate Note Due June 2027 at 3 Point 45 Percent [Member]
Debt Instrument [Line Items]
Long-term debt	500,000		500,000		500,000	$ 500,000
Fixed Rate Note Due November 2018 at 2 Point 50 Percent [Member]
Debt Instrument [Line Items]
Long-term debt	0		0		500,000
Stated interest rate of the notes						2.50%	2.50%	2.50%
Effective interest rate of the Notes								2.60%
Net Proceeds From Issuance of Long Term Debt 4								$ 494,500
Fxed Rate Note Due March 2023 at 3 Point 375 Percent [Member]
Debt Instrument [Line Items]
Long-term debt	$ 500,000		$ 500,000		$ 500,000				$ 500,000
Effective interest rate of the Notes									3.50%
proceeds from issuance of long term debt 3									$ 490,000
FixedRateNoteDueJune2027at3Point450Percent[Member] [Member]
Debt Instrument [Line Items]
Stated interest rate of the notes						3.45%	3.45%
Fixed Rate Note Due June 2027 at 3 Point 50 Percent [Member] [Domain]
Debt Instrument [Line Items]
Effective interest rate of the Notes						3.50%
Fixed Rate Note Due June 2027 at 3 Point 50 Percent [Member] [Member]
Debt Instrument [Line Items]
Net Proceeds From Issuance of Long Term Debt 5						$ 495,200
Fixed Rate Note Due March 2023 at 3 Point 375 Percent [Member]
Debt Instrument [Line Items]
Stated interest rate of the notes						3.375%	3.375%		3.375%

Financial Instruments Financi_2

Financial Instruments Financial Instruments, Credit Facility (Details) - Unsecured Revolving Credit Facility [Member] $ in Millions	12 Months Ended
	Jun. 24, 2017	Dec. 29, 2018USD ($)
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 350
Debt Instrument, Covenant Requirement, Ratio of Debt to EBITDA	3
Debt Instrument, Convenant Requirement, minimum interest coverage ratio	3.5

Financial Instruments Gain (Los

Financial Instruments Gain (Loss) from Hedging Activities (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 29, 2018	Dec. 30, 2017
Derivative [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 576,906	$ 622,637	$ 1,215,401	$ 1,198,313
Cost of Revenue	203,858	212,961	412,117	414,806
Revenues	576,906	622,637	1,215,401	1,198,313
Operating Expenses	190,844	$ 208,628	386,898	397,293
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			(2,570)	$ 1,192
Accumulated Net Gain (Loss) from Cost of Good Solds Attributable to Parent [Member] [Member]
Derivative [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	(82)		(596)
Accumulated Net Gain (Loss) from Operating Expense Attributable to Parent [Member] [Member] [Member]
Derivative [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	(602)		(1,827)
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Derivative [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	$ 5		$ 44

Stock-Based Compensation (Detai

Stock-Based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 29, 2018	Dec. 30, 2017
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	$ 21,656	$ 21,038	$ 42,153	$ 38,327
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	2,304	1,887	4,268	4,777
Net stock-based compensation expense	19,352	19,151	37,885	33,550
Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	2,388	2,486	4,667	4,887
Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	9,839	10,116	19,696	17,983
General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	9,429	8,436
Stock options [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	78	482	155	1,239
Stock options [Member] | Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	9	75	19	161
Stock options [Member] | Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	11	185	22	493
Stock options [Member] | General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	58	222
Restricted Stock Units (RSUs) [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	19,350	18,498
Restricted Stock Units (RSUs) [Member] | Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	1,884	1,944	3,646	3,780
Restricted Stock Units (RSUs) [Member] | Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	8,693	8,898	17,384	15,487
Restricted Stock Units (RSUs) [Member] | General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	8,773	7,656
ESP Plan [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	2,228	2,058	4,551	4,035
ESP Plan [Member] | Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	495	467	1,002	946
ESP Plan [Member] | Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	1,135	1,033	2,290	2,003
ESP Plan [Member] | General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	598	558
Market stock units [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	$ 2,900	$ 2,200	$ 5,300	$ 3,600

Stock-Based Compensation, Stock

Stock-Based Compensation, Stock Option Plans (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	6 Months Ended
	Dec. 29, 2018	Dec. 29, 2018	Dec. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Unrecognized compensation costs related to unvested units	$ 170,400	$ 170,400
Weighted average period of recognition for unrecognized compensation costs (in years)		2 years 10 months 30 days	2 years 10 months 30 days
Stock options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options outstanding, beginning		1,688,253,000
Options Granted	0
Options Exercised	(522,499,000)
Options Cancelled	(3,439,000)
Options outstanding, ending	1,162,315,000	1,162,315,000
Options exercisable, number of shares	1,162,315,000	1,162,315,000
Options vested and expected to vest, number of shares	1,162,315,000	1,162,315,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options outstanding, weighted average exercise price, beginning (per share)		$ 27.72
Options granted, weighted average exercise price (per share)
Options exercised, weighted average exercise price (per share)	26,960
Options cancelled, weighted average exercise price (per share)	28,080
Options outstanding, weighted average exercise price, ending (per share)	28,060	28,060
Options exercisable, weighted average exercise price (per share)	28,060	28,060
Options vested and expected to vest, weighted average exercise price (per share)	$ 28,060	$ 28,060
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Options outstanding, weighted average remaining contractual term (in years)		1 year 5 months 26 days
Options exercisable, weighted average remaining contractual term (in years)		1 year 5 months 26 days
Options vested and expected to vest, weighted average remaining contractual term (in years)		1 year 5 months 26 days
Options outstanding, aggregate intrinsic value	$ 24,126,273	$ 24,126,273
Options exercisable, aggregate intrinsic value	24,126,273	24,126,273
Options vested and expected to vest, aggregate intrinsic value	24,126,273	24,126,273
Unrecognized compensation costs related to unvested units	$ 0	$ 0

Stock-Based Compensation, Restr

Stock-Based Compensation, Restricted Stock Units (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 29, 2018	Dec. 30, 2017
Outstanding and expected to vest RSUs [Roll Forward]
Outstanding, ending	1,100,000	5,700,000	1,100,000	5,700,000
Unrecognized compensation costs related to unvested units	$ 170,400		$ 170,400
Weighted average period of recognition for unrecognized compensation costs (in years)			2 years 10 months 30 days	2 years 10 months 30 days
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (per share)	$ 50.90	$ 50.36	$ 54.71	$ 42.41
Outstanding and expected to vest RSUs [Roll Forward]
Outstanding, beginning			5,524,432,000
Granted	1,321,125,000
Released	(802,916,000)
Cancelled	(325,807,000)
Outstanding, ending	5,716,834,000		5,716,834,000
Expected to vest, number of shares	4,743,351,000		4,743,351,000
Outstanding, weighted average remaining contractual term (in years)	2 years 10 months 30 days
Restricted stock units vested and expected to vest, weighted average remaining contractual term 1	2 years 9 months 25 days
Outstanding, aggregate intrinsic value	$ 279,095,836		$ 279,095,836
Restricted stock units expected to vest, aggregate intrinsic value	231,570,395		231,570,395
Value of restricted stock unit shares withheld for withholding tax	$ 5,900		$ 13,400

Stock-Based Compensation Stock

Stock-Based Compensation Stock Based Compensation, Market Stock Units (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 29, 2018	Dec. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangements by Share-based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]			The following table summarizes the number of MSUs outstanding and expected to vest as of December 29, 2018 and their activity during the six months ended December 29, 2018 : Number of Shares Weighted Average Aggregate Intrinsic (1) Balance at June 30, 2018 1,079,064 Market stock units granted 247,804 Market stock units released (13,594 ) Market stock units cancelled (250,190 ) Balance at December 29, 2018 1,063,084 2.9 $ 51,889,761 Outstanding and expected to vest, December 29, 2018 960,920 2.9 $ 46,912,120 (1) Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on December 28, 2018, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of December 29, 2018.
Allocated Share-based Compensation Expense	$ 21,656	$ 21,038	$ 42,153	$ 38,327
Outstanding and expected to vest MSUs [Roll Forward]
Outstanding, ending	1,100,000	5,700,000	1,100,000	5,700,000
Unrecognized compensation costs related to unvested units	$ 170,400		$ 170,400
Weighted average period of recognition for unrecognized compensation costs (in years)			2 years 10 months 30 days	2 years 10 months 30 days
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 2,900	$ 2,200	$ 5,300	$ 3,600
Market Stock Units [Member]
Outstanding and expected to vest MSUs [Roll Forward]
Weighted average grant date fair value (per share)			$ 75.48	$ 51.03
Outstanding, beginning			1,079,064,000
Granted	247,804,000
Released	(13,594,000)
Cancelled	(250,190,000)
Outstanding, ending	1,063,084,000		1,063,084,000
Expected to vest, number of shares	960,920,000		960,920,000
Outstanding, weighted average remaining contractual term (in years)	2 years 10 months 30 days
Outstanding and expected to Vest, weighted average remaining contractual term 3	2 years 10 months 30 days
Outstanding, aggregate intrinsic value	$ 51,889,761		$ 51,889,761
Outstanding and expected to vest, aggregate intrinsic value	46,912,120		46,912,120
Unrecognized compensation costs related to unvested units	$ 35,000		$ 35,000

Stock-Based Compensation, Emplo

Stock-Based Compensation, Employee Stock Purchase Plan (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 29, 2018	Dec. 30, 2017	Jun. 30, 2018	Sep. 23, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 21,656	$ 21,038	$ 42,153	$ 38,327
Risk-free interest rate	1.60%	0.80%	1.60%	0.80%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	2.10%	3.00%	2.10%	3.00%
Unrecognized compensation costs related to unvested units	$ 170,400		$ 170,400
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			2 years 10 months 30 days	2 years 10 months 30 days
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	2,304	$ 1,887	$ 4,268	$ 4,777
Allocated Share-based Compensation Expense, Net of Tax	$ 19,352	$ 19,151	$ 37,885	$ 33,550
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum	2.60%	1.50%	2.60%	1.50%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum	19.60%	19.10%	19.60%	19.10%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum	32.69%	24.70%	32.69%	24.73%
Share Based Compensation Arrangement By Share Based Payment Award, Fair Value Assumptions, Expected Dividend Rate, Maximum	3.14%	3.37%	3.14%	3.37%
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 2,900	$ 2,200	$ 5,300	$ 3,600
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	1,162,315,000		1,162,315,000		1,688,253,000
Allocated Share-based Compensation Expense	$ 78	482	$ 155	1,239
Unrecognized compensation costs related to unvested units	0		0
ESP Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 2,228	$ 2,058	$ 4,551	$ 4,035
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	6 months	6 months	6 months	6 months
Unrecognized compensation costs related to unvested units	$ 8,600		$ 8,600			$ 6,500
Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	19,350	$ 18,498
Cost of Sales [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	2,388	2,486	4,667	$ 4,887
Cost of Sales [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	9	75	19	161
Cost of Sales [Member] | ESP Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	495	467	1,002	946
Cost of Sales [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	1,884	1,944	3,646	3,780
Research and Development Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	9,839	10,116	19,696	17,983
Research and Development Expense [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	11	185	22	493
Research and Development Expense [Member] | ESP Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	1,135	1,033	2,290	2,003
Research and Development Expense [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	8,693	8,898	$ 17,384	$ 15,487
General and Administrative Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	9,429	8,436
General and Administrative Expense [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	58	222
General and Administrative Expense [Member] | ESP Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	598	558
General and Administrative Expense [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 8,773	$ 7,656

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 29, 2018	Dec. 30, 2017
Numerator for basic earnings per share and diluted earnings per share
Net income	$ 131,892	$ (75,015)	$ 329,315	$ 79,519
Denominator for basic earnings per share	276,252	281,560	277,144	281,852
Effect of dilutive securities
Stock options, ESPP and RSUs	3,756	0	4,270	4,503
Denominator for diluted earnings per share	280,008	281,560	281,414	286,355
Earnings per share, Basic (per share)	$ 0.48	$ (0.27)	$ 1.19	$ 0.28
Earnings per share, Diluted (per share)	$ 0.47	$ (0.27)	$ 1.17	$ 0.28
Antidilutive securities excluded from computation of earnings per share	0	4,800	0	0

Segment Information (Details)

Segment Information (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2018USD ($)customers	Dec. 30, 2017USD ($)	Dec. 29, 2018USD ($)	Dec. 30, 2017USD ($)	Jun. 30, 2018USD ($)
Segment Reporting Information [Line Items]
Number of Reportable Segments | customers	1
Revenues	$ 576,906	$ 622,637	$ 1,215,401	$ 1,198,313
Long-lived assets	571,983		571,983		$ 579,364
United States [Member]
Segment Reporting Information [Line Items]
Revenues	64,845	82,620	136,974	147,261
Long-lived assets	358,571		358,571		361,432
China [Member]
Segment Reporting Information [Line Items]
Revenues	208,717	230,188	428,015	442,953
Rest of Asia [Member]
Segment Reporting Information [Line Items]
Revenues	186,840	182,953	407,221	363,903
Europe [Member]
Segment Reporting Information [Line Items]
Revenues	100,662	111,550	212,030	215,684
Philippines [Member]
Segment Reporting Information [Line Items]
Long-lived assets	111,408		111,408		120,657
Rest of World [Member]
Segment Reporting Information [Line Items]
Revenues	15,842	$ 15,326	31,161	$ 28,512
Long-lived assets	$ 102,004		$ 102,004		$ 97,275

Comprehensive Income Loss Accum

Comprehensive Income Loss Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 29, 2018	Dec. 30, 2017
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax		$ (11,792)	$ (14,985)	$ (9,890)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			1,654	(495)
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			2,570	(1,192)
Other Comprehensive Income (Loss), Tax			(575)	(215)
Other Comprehensive Income (Loss), Net of Tax	$ 1,384	(2,201)	3,649	(1,902)
Accumulated Other Comprehensive Income (Loss), Net of Tax	(11,336)		(11,336)
Unrealized Holding Gains (Losses) on Intercompany Receivables [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax		(6,280)		(6,280)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			0	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			0	0
Other Comprehensive Income (Loss), Tax			0	0
Other Comprehensive Income (Loss), Net of Tax			0	0
Accumulated Other Comprehensive Income (Loss), Net of Tax	(6,280)		(6,280)
Accumulated Defined Benefit Plans Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax		(1,290)	(2,516)	(1,258)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			0	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			191	132
Other Comprehensive Income (Loss), Tax			(37)	(164)
Other Comprehensive Income (Loss), Net of Tax			154	(32)
Accumulated Other Comprehensive Income (Loss), Net of Tax	(2,362)		(2,362)
Accumulated Translation Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax		(1,136)	(1,136)	(1,136)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			0	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			0	0
Other Comprehensive Income (Loss), Tax			0	0
Other Comprehensive Income (Loss), Net of Tax			0	0
Accumulated Other Comprehensive Income (Loss), Net of Tax	(1,136)		(1,136)
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax		368	(1,383)	18
Other Comprehensive Income (Loss), before Reclassifications, before Tax			(551)	1,725
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			2,379	(1,324)
Other Comprehensive Income (Loss), Tax			(310)	(51)
Other Comprehensive Income (Loss), Net of Tax			1,518	350
Accumulated Other Comprehensive Income (Loss), Net of Tax	135		135
Unrealized Holding Gains (losses) on Available-for-sale Investments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax		$ (3,454)	(3,670)	(1,234)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			2,205	(2,220)
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			0	0
Other Comprehensive Income (Loss), Tax			(228)	0
Other Comprehensive Income (Loss), Net of Tax			1,977	$ (2,220)
Accumulated Other Comprehensive Income (Loss), Net of Tax	$ (1,693)		$ (1,693)

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 29, 2018	Dec. 30, 2017	Jun. 24, 2017
Effective Income Tax Rate Reconcilliation, Share-based Compensation, Excess Tax Benefit, Amount [Line Items]
Unrecognized Tax Benefits, Interest on Income Taxes Expense		$ 4,200
Unrecognized Tax Benefits	$ 444,000		$ 444,000
Advance payments for audit and post-audit year tax				$ 140,700
Interest payment on advance payments for audit and post-audit year tax				37,400
Provision for income taxes	$ 50,784	$ 272,942	$ 86,997	$ 299,361
Effective Income Tax Rate Reconciliation, Percent	27.80%	137.90%	20.90%	79.00%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%			0.00%	35.00%
Effective Income Tax Reconciliation, Deferred Tax Remeasurement		$ 13,700
Effective Income Tax Reconciliation, Transition Tax		$ 236,900	$ 22,100
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent	12.10%		5.30%
Effective Income Tax Reconciliation, Interest Accruals	$ 4,900		$ 9,400

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Mar. 31, 2018
Business Acquisition, Contingent Consideration [Line Items]
Business Combination, Contingent Consideration, Liability	$ 8,000	$ 16,000

Common Stock Repurchases (Detai

Common Stock Repurchases (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended		6 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 29, 2018	Dec. 30, 2017	Oct. 30, 2018	Jul. 20, 2017
Equity, Class of Treasury Stock [Line Items]
Stock Repurchased During Period, Shares			5.8
Stock Repurchased During Period, Value			$ 320,100
Stock repurchase program, authorized amount					$ 2,000,000	$ 1,000,000
Value of common stock repurchased	$ 207,558	$ 76,954	320,056	$ 152,246
Stock repurchase program, remaining authorized amount	$ 1,334,100		$ 1,334,100

Acquisitions (Details)

Acquisitions (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Mar. 31, 2018	Dec. 29, 2018	Dec. 30, 2017	Jun. 30, 2018
Business Acquisition [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired	$ 57,800	$ 2,949	$ 0
Business Combination, Contingent Consideration, Liability	16,000			$ 8,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	26,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	10,500
Goodwill	$ 41,889	$ 532,251		$ 532,251

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Goodwill (Details) - USD ($) $ in Thousands	Dec. 29, 2018	Jun. 30, 2018	Mar. 31, 2018
Goodwill [Line Items]
Goodwill	$ 532,251	$ 532,251	$ 41,889

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 29, 2018	Dec. 30, 2017	Jun. 30, 2018
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	$ 617,825		$ 617,825		$ 613,599
Accumulated Amortization	553,454		553,454		538,143
Net	64,371		64,371		75,456
Intangible Assets, Gross	620,615		620,615		616,389
Total purchased intangible assets	67,161		67,161		78,246
Cost, Amortization	6,868	$ 11,140	13,783	$ 22,204
Amortization of Intangible Assets	756	995	1,529	2,747
Intangible Asset Amortization Expense	7,624	$ 12,135	15,312	$ 24,951
Future amortization expense [Abstract]
Remaining three months of 2017	10,918		10,918
2,019	15,068		15,068
2,020	13,368		13,368
2,021	7,689		7,689
2,022	7,205		7,205
Thereafter	10,123		10,123
Net	64,371		64,371		75,456
Intellectual Property [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	488,846		488,846		485,465
Accumulated Amortization	437,652		437,652		423,869
Net	51,194		51,194		61,596
Future amortization expense [Abstract]
Net	51,194		51,194		61,596
Customer relationships [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	116,505		116,505		116,294
Accumulated Amortization	104,557		104,557		103,217
Net	11,948		11,948		13,077
Future amortization expense [Abstract]
Net	11,948		11,948		13,077
Tradename [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	9,974		9,974		9,340
Accumulated Amortization	8,745		8,745		8,588
Net	1,229		1,229		752
Future amortization expense [Abstract]
Net	1,229		1,229		752
Patents [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	2,500		2,500		2,500
Accumulated Amortization	2,500		2,500		2,469
Net	0		0		31
Future amortization expense [Abstract]
Net	0		0		31
In Process Research and Development [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
IPR&D	$ 2,790		$ 2,790		$ 2,790

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 29, 2018	Dec. 30, 2017	Jun. 30, 2018
Long Lived Assets Held-for-sale [Line Items]
Asset Impairment Charges	$ 753	$ 850	$ 753	$ 892	$ 900
Gain (Loss) on Disposition of Property Plant Equipment			$ (2,896)	$ 588

Restructuring Activities (Detai

Restructuring Activities (Details) - $ / shares	3 Months Ended		6 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 29, 2018	Dec. 30, 2017
Restructuring Cost and Reserve [Line Items]
Earnings per share, Diluted (per share)	$ 0.47	$ (0.27)	$ 1.17	$ 0.28

Restructuring Activities Change

Restructuring Activities Change in Estimate (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Dec. 29, 2018	Dec. 30, 2017
Change in Accounting Estimate [Line Items]
Operating Income (Loss)	$ 182,204	$ 201,048	$ 416,386	$ 386,214
Net income	$ 131,892	$ (75,015)	$ 329,315	$ 79,519
Basic (per share)	$ 0.48	$ (0.27)	$ 1.19	$ 0.28
Diluted (per share)	$ 0.47	$ (0.27)	$ 1.17	$ 0.28

Uncategorized Items - mxim-2018

Label	Element	Value
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	$ 2,202,694,000
AOCI Attributable to Parent [Member]
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	(9,890,000)
Retained Earnings [Member]
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	2,212,301,000
Common Stock [Member]
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	283,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	$ 279,000